Metabolism of Testosterone Following Continuous Infusion of [ 3h] Testosterone: Effect of Orchiectomy and Testicular Atrophy by Peterson, James Eugene
METABOLISM OF TESTOSTERONE FOLLOWING CONTINUOUS 
INFUSION OF [3H] TESTOSTERONE: EFFECT OF 
ORCHIECTOMY AND TeSTICULAR ATROPHY 
By 
JAMES EUGENE PETERSON ,, 
Bachelor of Science 
Rutgers University 
New Brunswick, New Jersey 
1970 
Submitted to the Faculty of the Graduate College 
of the Oklahoma State University 
in partial fulfillment of the requirements 
for the Degree of 
DOCTOR OF PHILOSOPHY 
May, 1976 
' --r/t(l~ 
J 17ft., 1J 
-p l(85~rt~' 
e-t;-f· ~ 
METABOLISM OF TESTOSTERONE FOLLOWING CONTINUOUS 
INFUSION OF [3H] TESTOSTERONE: EFFECT OF 
ORCHIECTOMY AND TESTICULAR ATROPHY 
Thesis Approved: 
ii 
ACKNOWLEDGEMENTS 
My sincere appreciation goes to Dr. Claude Desjardins for his 
guidance and understanding throughout this study and for the use of his 
facilities at the Department of Zoology, University of Texas. 
The author is grateful also for the assistance provided by Dr. John 
H, Venable during this study and appreciation is expressed to Dr. H. Olin 
Spivey, Dr. Robert Wetteman and Dr. Patrick Mayer for council during the 
years of my graduate study. 
Further gratitude is expressed to members of the faculty, staff and 
graduate students of the Department of Physiological Sciences, Oklahoma 
State University, Department of Zoology, University of Texas, and Depart-
ment of Physiology and Biophysics, Colorado State University for their 
assistance. 
For personal financial aid during the course of this study, thanks 
are extended to NDEA for Fellowship No. 71-002507. 
Finally, this acknowledgement would not be complete without a very 
special expression of gratitude to my wife, Rita. Her understanding and 
support made this endeavor possible. 
iii 
TABLE OF CONTENTS 
Chapter 
I. INTRODUCTION 
II. REVIEW OF LITERATURE 
III. 
Introduction. , . • • . . . . . • . . • 
The Uptake and Metabolism of Labeled Testosterone by 
Different Tissues • • • . . . • . . . . 
Liver. . . . • • . , 
Brain and Anterior Pituitary . 
Ventral Prostate . 
Testis . . , . , . , . . . . 
Steroid Diffusion Through Silicone Rubber . 
Steady State and Infusion Techniques. 
Summary , , • • . II,' II II II II II 
MATERIALS AND METHODS. 
• 0 ' 
Materials . . , • . . 
Animals. , .•. 
Silicone Rubber. . . , . . 
Infusion Materials . 
Tubing ... . 
Pump ... a o • • • o o • 
Restraining Cage .. 
Nonradioactive Steroids ..... 
Steroid Derivatives .. 
Acetates .•....• 
Methoximes ... , , 
Derivatization Compounds . , . , . 
Scintillation Counting Material .. 
Reagents e • o , • o • o , o • e • o • • o 
Glassware ••.•..... 
Chromatographic Materials ... , ..... . 
Adsorbents. , 
Development . , , , • , . , 
Visualization Spray 
Radioactive Isotopes • . 
Solution for Tissue Homogenization . 
Methods . . . . . • . . . . . . . . . . . 
Animal Housing and Preparation . • • • 
Polydimethylsiloxane Capsule Preparation and 
Implantation . • . • , . . . . • . , . 
.. 
• .• e 
Recrystallization of Nonradioactive Steroids . . 
iv 
Page 
1 
4 
4 
6 
7 
14 
21 
23 
26 
28 
30 
31 
31 
31 
31 
31 
31 
31 
32 
32 
32 
32 
32 
33 
33 
33 
34 
34 
34 
34 
34 
35 
35 
35 
35 
36 
36 
Chapter Page 
IV. 
Preparation of [4- 14c] Sa-androstanedione and 
[4-14C]-androsterone .•.••.• o , • , • • 37 
Preparation of Indwelling Catheters and 
Connecting Cannulas. 0 , ••• 0 • 0 ••• , • 37 
Surgical Procedure . . . • . • • . • , 38 
Infusion of Radiolabeled Testosterone. . . . . 39 
Tissue Collection and Homogenization . o • • • • 39 
Extraction of Testosterone Metabolites . , . o o 42 
Separation of Testosterone Metabolites by Thin-Layer 
Chromatography (TLC) . . . . • • . . , . 42 
Derivative Formation , , . . . . . , . . • 47 
Quench Correction and Calculations to Arrive at dpm 
of an Isolated Steroid . . , • . . , o • • • 51 
Experimental Design . . . . , , 0 • • , , o , • • • • , • 52 
Experiment 1: Determination of Testosterone Release 
Rate and the Influence of Different Circulating 
Androgen Titers on the Testis and Seminal Vesicle 
Weights. . . . . o f) ~ • • llo • • • • • I) o • o fl • 53 
Experiment 2: Determination of the Time Required to 
Establish Steady State Conditions for Plasma 
Testosterone • . • , , . . . • . • 0 • • • o • • o 54 
Experiment 3: Differential Metabolism of [3H] and 
[14c] Testosterone Following Constant Infusion 
for 3 Hours . . . o • • • • 6 • • o • • • • o • • o 54 
Experiment 4: Distribution of [3H] Testosterone and 
Some of its Tritiated Metabolites Following 
Infusion of [l-2-6,7-3H] Testosterone in Normal, 
Castrate and Testosterone Treated Male Rats. . 55 
Experiment 5: Distribution of [3H] Testosterone and 
Some of its Tritiated Metabolites Following 
Constant Infusion of [7-3H] Testosterone in 
Normal, Castrate and Testosterone Treated Male 
Rats . o o • o • • • • fl • 56 
RESULTS. . 
Experiment 1: Determination of Testosterone Release 
Rate and the Influence of Different Circulating 
Androgen Titers on the Testis and Seminal Vesicle 
Weights o • • o • • • • o • • • • 
Experiment 2: Determination of the Time Required to 
Establish Steady State Conditions for Plasma 
Testosterone. • • • • • , o • • • • • • • • • • 
Experiment 3: Differential Metabolism of [3H] and [14c] 
Testosterone Following Constant Infusion for 3 Hours .. 
Experiment 4: Distribution of [3H] Testosterone and Some 
of its Tritiated Metabolites Following Infusion of 
[1,2,6,7-3H] Testosterone for 3 Hours in Normal, Cas-
trate, and Testosterone Treated Male Rats .••.. 
Pituitary Gland. . . ...• 
Hypothalamus . • . 
Cerebral Cortex. 
v 
57 
57 
59 
59 
62 
62 
69 
69 
Chapter 
v. 
VI. 
Page 
Prostate . 69 
Testis 70 
Liver. 70 
Plasma . . . . . 73 
Experiment 5: Distribution of [3H] Testosterone and Some 
of its Tritiated Metabolites Following Infusion of 
[7-3H] Testosterone in Normal, Castrate and 
Testosterone Treated Male Rats. 73 
Pituitary Gland. 73 
Hypothalamus 82 
Cerebral Cortex. 82 
Prostate . 
Testis 
Liver. 
Plasma . 
DISCUSSION . 
SUMMARY AND CONCLUSIONS. 
83 
83 
86 
86 
89 
• 101 
SELECTED BIBLIOGRAPHY . • 103 
APPENDIX. . 112 
vi 
Table 
I. 
II. 
III. 
IV. 
v. 
VI. 
LIST OF TABLES 
Calibration of Harvard Infusion Pump (Series 900) ..• 
Verification of Procedures Used to Extract and Isolate 
Testosterone and Some of its Metabolites •.•. 
Evidence for the Radiochemical Purity of Testosterone and 
Related Steroid Derivatives .....••. , ..... . 
Evidence for the Radiochemical Purity of Testosterone and 
Related Steroid Derivatives by Using an Internal Standard .. 
Testis and Seminal Vesicle Wet and Dry Weights of Normal, 
Castrate and Testosterone Treated Male Rats and the Mean 
Release Rate of the 200 mm2 Silastic Capsules •.. , . , 
. 3 
Radiotestosterone Clearance Rate of [ H] Testosterone of 
Adult Male Rats at the end of 3 or 4 Hour Infusions With 
11,2 ,6, 7-3H] or [7-3H] Testosterone. • . . . • . . . 0 • 
VII. The Tissue: Infusion Ratio Following Infusion of [1,2,6,7-3H] 
or [7-3H] and [4-14c] Testosterone for 3 Hours in Various 
Tissues of Normal, Castrate and Testosterone Treated Male 
Rats ... 
VIII. Distribution of Testosterone and Some of its Tritiated 
Metabolites Following Infusion of [1,2,6,7-3H] Testosterone 
for 3 Hours Into Normal (N), Castrate (C) and Testosterone 
Page 
40 
43 
48 
so 
58 
60 
61 
Treated (TT) Male Rats . . • . , . . . . . . o • • • o • 67 
IX. Distribution of Testosterone and Some of its Tritiated 
Metabolites Following Infusion of [7-3H] Testosterone for 
3 Hours Into Normal (N), Castrate (C) and Testosterone 
Treated (TT) Male Rats • . . . . . . . . . . . . . . . . . . 80 
vii 
LIST OF FIGURES 
Figure 
1. 
2. 
3. 
4. 
5, 
6. 
7. 
8, 
9. 
lOo 
Some of the Metabolites of Testosterone With the Enzymes 
Believed to be Involved in Their Transformations 
Thin Layer Chromatography Systems Used to Separate Testosterone 
and Some of its Metabolites .. o • • • •• , •• o 
Relative Percentage of Isolated Compounds in Cerebral Cortex, 
Hypothalamus and Pituitary of Normal, Castrate and Testos-
terone Treated Male Rats Following 3 Hr Infusion of 
[1,2,6,7-3H] Testosterone, . , .•••.• , . , , .. 
Radioactive Concentration of Testosterone (dpm x 1031100 mg 
Tissue) in Various Tissues of Normal, Castrate and Testos-
terone Treated Male Rats Following 3 Hr Infusion of 3 . [1,2,6,7- H] Testosterone .•. o • , , •••• , •• 
Relative Percentage of Isolated Compounds in Prostate, Testis 
and Liver of Normal, Castrate and Testosterone Treated Male 
Rats Following 3 Hr Infusion of [1,2,6,7-3H] Testosterone ••. 
Relative Percentage of Isolated Compounds in Plasma of Normal, 
Castrate and Testosterone Treated Male Rats Following 3 Hr 
Infusion of [1,2,6,7-3H] Testosterone .•..•.•.• , ... 
Relative Percentage of Isolated Compounds in Cerebral Cortex, 
Hypothalamus and Pituitary of Normal, Castrate and Testos-
terone Treated Male Rats Following 3 Hr Infusion of [7-3H] 
Testosterone . , o o • o o • • (I • • o • o • "' (I o o o 
Radioactive Concentration of Testosterone (dpm x 103/100 mg 
Tissue) in Various Tissues of Normal, Castrate and Testos-
terone Treated Male Rats Following 3 Hr Infusion of [7-3H] 
Testosterone . o e • • • , o o o • • • • • • o o o • 
Relative Percentage of Isolated Compounds in Prostate, Testis 
and Liver of Normal, Castrate and Testosterone Treated Male 
Rats Following 3 Hr Infusion of [7-3H] Testosterone ....• , 
Relative Percentage of Isolated Compounds in Plasma of Normal, 
Castrate and Testosterone Treated Male Rats Following 3 Hr 
Infusion of [7-3H] Testosterone .... , ....•. , . o • , 
viii 
Page 
9 
45 
64 
66 
72 
75 
77 
79 
85 
88 
CHAPTER I 
INTRODUCTION 
Every civilization has manifested a desire to avoid excessive 
sterility and fertility, but there has always been a gap between the de-
sire to control conception and its effective prevention. Dwindling 
energy reserves, food shortages, and rising prices make people well aware 
of the demands placed on our technical and natural resources by an ever 
increasing world population. Although the birth rate is declining in 
many nations, substantial advances in medical care and in the prevention 
and treatment of disease has increased the life expectancy of each indi-
vidual. The limited resources and unchecked population growth make the 
future look bleak and demonstrate the need to develop birth control 
measures to ensure adequate food and energy for everyone . 
Recent developments in the use of orally active hormonal steroids 
point to the acceptability of this mode of contraception. However, this 
procedure has only proven acceptable in females and thus excludes about 
half of the world's population, At the present time there is no accept-
able chemical contraceptive for men because the dose of hormone needed 
can not be achieved by oral administration of steroids. The birth 
control method developed for men must be safe, relatively inexpensive, 
effective, reversible, not change libido or nonsexual behavior, and not 
interfere with coitus . 
The administration of steroid hormones via subcutaneous 
1 
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polydimethysiloxane implants offers promise in fulfilling some of the 
above requirements for a method of birth control and also could be avail-
able to a majority of the world's population, Use of the proper size 
testosterone-filled implant could cause azospermia, via a decrease in the 
levels of plasma gonadotropins while maintaining the plasma testosterone 
levels near normal (Frick, 1973), The normal level of testosterone could 
maintain libido while the individual would be essentially sterile, The 
method could be reversible by simply removing the implant or not re-
placing an empty implant by a new one. While the use of subdermal 
Silastic implants for birth control in humans appears to satisfy the re-
quirements for a birth control procedure, additional studies are needed 
to understand and explain the inhibitory action of testosterone on the 
male reproductive system. 
In normal animals and man, pituitary gonadotropin release is regu-
lated, in part, by circulating testosterone titers by a so called nega-
tive feedback loop (Davidson, 1969). However, recent observations in 
laboratory animals indicate that testosterone-filled Silastic capsules 
can suppress pituitary gonadotropin secretion even though plasma testos-
terone concentration remains with the normal range (Berndtson, ~ al., 
1974), A number of explanations for this adjustment of the normal feed-
back response in the testosterone treated animal are possible, First, 
testosterone could be converted under conditions of greater mass movement 
of testosterone to a metabolite that suppresses pituitary gonadotropin 
secretion , A correlate to this explanation could be a change in the 
localization or binding of testosterone or one of its metabolites in cer-
tain tissues , Secondly, a change in the amount of free versus bound 
testosterone in the plasma of the testosterone treated animal could be 
3 
important since the free steroid is thought to be the active form of tes-
tosterone (Vermeulen and Verdonck, 1969). Thirdly, the sustained release 
of testosterone from the Silastic capsule could interrupt the episodic 
pattern of testosterone secretion and be important since the episodic 
bursts of plasma testosterone are believed to be correlated with the re-
lease of gonadotropins (Bartke, ~~·· 1973). 
One explanation for the action of a subdermal testosterone-filled 
Silastic implant is that there is a change in the uptake and/or metabo-
lism of testosterone . This explanation is easiest to investigate due to 
the availability of the method of constant infusion. Continuous infusion 
rather than a single injection of radiolabeled testosterone may more 
closely mimic the metabolism of endogenous testosterone , Since castra-
tion of male rats and the concomitantly lower plasma androgen levels 
cause a significant increase in the uptake of radiolabeled testosterone 
in various tissues (Bruchovsky and Wilson, 1968), castrate animals will 
be used in the present study in addition to normal and testosterone 
treated animals to ascertain the effects of low androgen exposure on 
testosterone metabolism, Comparison of the uptake and metabolism of tes -
tosterone following constant infusion with that found previ ously after 
single injection will aid in evaluation of the infusion procedure . 
Thus, the purposes of the present investigation were : 
·-~ (1) t o-.deter-
mine changes in the metabolism of infused testosterone in male rats 
exposed to diff erent levels of testosterone (castrate, normal, and tes-
tosterone treated), and (2) to determine any changes in the uptake and 
retention of infused testosterone or its tritiated metabolites in various 
t i ssues. 
CHAPTER II 
REVIEW OF LITERATURE 
Introduction 
Androgens have been used since the middle ages (Needham, 1968), In 
1100 A.D., the Chinese administered large quantities of testicular tis-
sues orally and developed a procedure to fractionate hundreds of gallons 
of human or animal urine, Precipitations and sublimations of urine 
yielded a white, crystalline material probably containing mixtures of 
androgens, estrogens and cholesterol, The Chinese were aware of a number 
of stimulating actions of these tissue or urinary extracts on the male 
reproductive organs and secondary sexual characteristics, Today, it is 
known that androgens affect almost every vertebrate tissue regardless of 
the genotypic sex, 
Androgens exert two fundamental actions (Young,~~· , 1964) : (1) 
they promote irreversible morphogenetic or organizational effects during 
a restricted period of fetal or early neonatal life, and (2) they exert 
reversible "activational" effects throughout the life span of the indi -
vidual, The first category includes the initial embryonic differentia-
tion of male accessory primordia such as the mesonephric ducts and 
urogenital sinus as well as the organizational action of androgens on 
structures in the central nervous system to cause acyclic production of 
pituitary gonadotropins and male patterns of copulatory behavior, The 
second category includes excitatory or inhibitory effects on the 
4 
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hypothalamo-hypophyseal-gonadal axis, differentiation of various male 
secondary sexual tissues and numerous effects on nonsexual tissues such 
as an increased vascularity of tissues, skeletal growth, and promotion of 
protein anabolism (Wilson, 1962). 
This review is concerned primarily with the uptake and metabolism of 
testosterone in various tissues and the experimental techniques used to 
investigate this retention. It will be divided into subcategories re-
flecting the approach to the following questions: (1) how does a normal 
circulating titer of testosterone provoke a reduced secretion of pitui-
tary luteinizing hormone (LH) and follicle-stimulating hormone (FSH) and 
(2) what effect do circulating androgen titers have on the uptake and 
metabolism of testosterone in tissues known to depend on this hormone. 
Background information will be provided demonstrating that the up-
take and metabolism of testosterone in the pituitary gland, hypothalamus, 
and cerebral cortex may be important since a metabolite of testosterone 
could regulate circulating levels of LH and FSH in animals receiving sub-
dermal testosterone capsules. In addition to the uptake and metabolism 
of testosterone in neural tissues, information will be presented on the 
fate of testosterone in hepatic (the homeostatic elimination organ), 
prostatic (the "classical" organ of androgen action), and testicular (the 
production organ) tissue in order to develop a comparative understanding 
of testosterone metabolism in animals receiving contraceptive doses of 
exogenous testosterone. 
A brief review of the history and use of polydimethylsiloxane cap-
sules for the sustained release of hormonal steroids will be included 
and the rationale and assumptions underlying the use of continuous in-
fusions and steady state will be discussed. 
6 
The Uptake and Metabolism of Labeled 
Testosterone by Different Tissues 
Early investigations identifying the sites of testosterone uptake in 
14 
animals relied upon C-labeled testosterone of low specific activity . 
14 Barry, et ~· (1952) were able to localize [4- C] testosterone only in 
the liver and kidney (the organs concerned with the excretion of the 
hormone) in laboratory mice and rats . Moreover, Dirscherl and Mosebach 
(1961) detected no retention of 14c in any organ or tissue of castrate 
. f . . . [4 14c] . . 11 m1ce a ter 1nJect1ng - testosterone 1ntraper1tonea y. However, 
Greer (1959) and Harding and Samuels (1962) found about twice as much 
radioactivity in the ventral prostate as in muscle, but the radioactivity 
in the prostate and blood was similar . 
All the investigators mentioned above used doses of testosterone 
greatly in excess of the physiological values expected in laboratory 
rodents and undoubtedly prevented the specific retention of this steroi d 
by its "target" tissues (Robel, et ~· , 1973) , The smallest dose of tes -
tosterone administered was 40 ~g and many of the doses exceeded 100 ~g. 
The availability of tritium labeled testosterone with a higher specific 
3 
activity permitted Chatfield and Wilson (1966) to demonstrate that [ H] 
testosterone preferentially accumulated in the prostate, seminal vesicles 
and preputial gland of castrate rats . In addition, Tveter and Attramadal 
(1968) injected approximately 1 ~g of [1,2 - 3H] testosterone intramuscu-
larly into adult rats 3 days after castration and noted that tritium was 
concentrated in the prostate and liver with a maximum concentration 1-2 
hr after injection . The amount of radioactivity incorporated was dimin -
ished by the simultaneous administration of unlabeled testosterone, 
demonstrating the specificity of the process involved in concentrating 
7 
testosterone within the prostate. 
In addition to the specific activity, the method used to administer 
radioactive testosterone to animals is also very important, Meli (1963) 
showed that subcutaneous (SC) or intramuscular (IM) injections of testos-
terone proprionate were more effective in preventing regression of the 
prostate and seminal vesicles than intraperitoneal (IP) injections , He 
hypothesized that SC or IM injections permitted testosterone to be ab-
sorbed more slowly and thus led to a more prolonged and sustained hor-
monal response, In comparison to SC or IM injections, IP injections were 
much less effective since most of the absorbed hormone passed into the 
portal system and was inactivated by the liver, Intravenous injections 
deliver the hormone directly into the circulatory system; the fate of the 
injected radioactive hormone thus mimics that of unlabeled endogenous 
hormone , 
A brief discussion of the rationale behind choosing each of the tis-
sues used in the present investigation along with recent findings per-
taining to the uptake and metabolism of testosterone in these tissues is 
presented below , A diagram depicting the enzymes involved in testoster -
one metabolism is shown in Figure 1 , 
Liver 
Since the liver is the most important organ in the control system 
regulating plasma steroid hormone levels (Schriefers, 1967), hepatic tes -
tosterone metabolism was investigated to assess the role of this homeo-
static tissue in animals receiving exogenous testosterone , Numerous 
factors are known to affect steroid metabolism in the liver: the sexua l 
state of the animal, stage of development, state of nourishment, 
Figure 1. Some of the Metabolites of Testosterone With the Enzymes 
Believed to be Involved in Their Transformations. (Compiled 
and redrawn from Dorfman and Ungar, 1965). 
(1) = 178-hydroxysteroid dehydli-ogenase 
(2) = 19-hydroxylase and aromatizing enzymes 
(3) = 17a-hydroxysteroid deh:rdrogenase 
(4) = il4-5a reductase 
(5) = il4-58 reductase 
(6) = 3a-hydroxysteroid dehydrogenase 
(7) = 38-hydroxysteroid dehydrogenase 
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conditions of stress and hormone treatment (Schriefers, 1967) . Thus, 
alterations in hepatic testosterone metabolism could be expected by 
changing the amount of testosterone administered . 
The enzymes involved in hepatic steroid metabolism can be grouped 
into hydrogenases (or reductases), dehydrogenases, hydroxylases and 
transferases . The major changes in the steroid molecule are reductive, 
particularly in ring A. ~4 -hydrogenases form Sa- and 58- isomers of vari-
4 
ous steroid by reducing the ~ double bond. The hydrogenases or 
reductases have a high degree of steric specificity . The ~4-sa-reductases 
have been localized in microsomes whereas the ~4-SB-reductases appear in 
highest concentration in the cytosol. The reductases require NADPH as a 
cofactor, and the systems are apparently irreversible (Forchi elli and 
Dorfman, 1956) . 
The majority of the secondary alcohols formed upon reduction of the 
3-ketone group of the steroid molecule have the 3a-configuration. The 
3a-hydroxysteroid dehydrogenases appear to be relatively nonspecific as 
far as structure outside of ring A is concerned, and these reversible 
enzymes can use either NAD or NADP (Tomkins, 1956) . Small amounts of 
3B- , 17B- , llB-, 20B-, 16B-, and 16a-hydrosteroid dehydrogenases have 
been found in the liver (Sweat,~~· · 1950; Repke and Samuels, 1964) , 
Thus, dehydrogenases seem to be present for all positions in the steroi d 
molecule where ketone-secondary alcohol interconversion could occur . 
However, the dehydrogenases do not seem as selective with respect to the 
general structure of the steroid substrate as the ~4 reductases . Most of 
the dehydrogenases utilize either NAD or NADP as cofactors, and the di-
rection of conversion depends on the relative concentrations of both sub-
strates and cofactors at any one time. 
11 
Hepatic steroid hydroxylases are not as important in steroid metabo-
lism as are the dehydrogenases and reductases, However, hydroxylations 
at the 2, 68, 7a, 15a, and 16a positions have been described (Starke and 
Kutova, 1962; Colas, 1962). Such hydroxylations require NADPH and oxygen 
and are essentially irreversible. A 178-dehydrogenase may be important 
in the conversion of estrone to estradiol (Brown and Marrian, 1957), 
The above three enzyme groups produce products that are more polar 
than testosterone but still not very hydrophilic. Therefore, they would 
not be readily displaced from plasma binding proteins and thus retained 
during the process of glomerular filtration by the kidneys if they were 
not converted largely to glucuronisides and sulfates . Conjugation of 
hormonal steroids to glucuronide and sulfate takes place primarily in the 
liver. Glucuronidase transfers glucuronic acid from uridine diphospho-
glucuronic acid to steroids with the formation of uridine diphosphate 
(Isselbacher, 1956), The sulfate is transferred from adenosine 3'-
phosphate-5'-phosphosulfate by enzymes in the liver supernatant (Robbins 
and Lipmann, 1956), Most androgens are excreted largely as the glu-
curonides. The glucuronide derivatives of steroid hormones readily pass 
the glomerulus, but the kidney clears sulfates much more slowly (Kellie 
and Smith, 1957). 
Although testosterone is conjugated to glucuronic acid by the liver, 
the action of hepatic reductases, dehydrogenases and hydroxylases cannot 
be ignored. The activity of these enzymes is extremely important since 
the ability of the liver to form conjugates is apparently dependent on 
the steroid structure of the glucuronic acid acceptor (Rao and Taylor, 
1965), 
Qualitative and quantitative aspects of androgen metabolism have 
12 
been shown to depend on genotypic sex (Schrieffers, 1967). Forchielli 
and Dorfman (19S6) found that the microsomal Sa-reductase of rat liver 
homogenates was higher in females than males. The administration of 
estradiol benzoate and testosterone proprionate in both normal and cas-
trate male rats, respectively, increased and decreased hepatic Sa-
reductase activity (Schrieffers, 1967). Breuer, et ~· (1968) found that 
the Sa-reductase activity present in the cytosol was partly inhibited by 
microsomal Sa-reductases , Although the total Sa-reductase activity de-
pends on the substrate used, tissue preparation (slices, microsomal 
fraction or homogenate) and experimental conditions, it is clearly higher 
in the liver of female than male rats (Schriefers, 1967), Hydroxylation 
of steroids by the liver, particularly 3a-hydroxysteroid dehydrogenase, 
was much higher in male than female rats (Oto, ~~., 1972) . In addi-
tion, Baulieu and Mauvais-Jarvis (1964) have found that androgen metabo-
lism in the liver of male rats proceeds via the 17S-hydroxy pathway and 
the 17-keto pathway predominates in the liver of female animals. Another 
sex-dependent enzyme system involves the formation of steroid glucuronides 
which was higher in male than female rats because of the yet unexplained 
higher formation of glucuronic acid in males (Rao and Taylor, 196S), 
Thus, hepatic androgen metabolism is mainly reductive in females and 
oxidative in males with hydroxylation about 40 times higher in liver from 
males than females, Castration or estradiol-treatment in male rats have 
a tendency to feminize their metabolisms, whereas androgen treatment 
causes a masculinization of metabolism, 
Besides sex-dependent changes in enzyme activities from livers of 
adult animals, a number of investigations have found age-dependent 
changes in enzyme activity related to the presence or absence of 
13 
testosterone during pre- or post-natal development, The ability of 
androgens to permanently direct or program the subsequent capacity of the 
liver to metabolize steroids has been reviewed by Einarsson, et ~· 
(1973), Einarsson has recognized the following categories of enzymes: 
(1) enzymes with a basal level regulated by nongonadal factors yet re-
versibly inducible by androgens including 28-, 6S-, and 18-hydroxylases 
and SS-reductase; (2) enzyme systems reversibly imprinted by androgens 
neonatally and reversibly stimulated by androgens post-pubertally, in-
cluding 2a-hydroxylase, the 3S- and 17S-hydroxysteroid dehydrogenases, 
and SS-reducta~e; and (3) enzyme systems primarily regulated by nongo-
nadal factors and only slightly affected by androgens including 7a- and 
16a-hydroxylases. These systems imprinted at birth required increasing 
amounts of testosterone proprionate and longer times to be imprinted as 
the category number increased (Gustafsson and Stenberg, 1974). 
Thus, exposure to testosterone in neonatal life opens the possibil-
ity for permanent activation or depression of certain enzyme systems in 
the liver at puberty , In marked contrast, the effect of exogenous tes-
tosterone on the activity of these hepatic enzyme systems in adulthood 
should be temporary since the process of hepatic differentiation has been 
completed (Denuf and DeMoor, 1968) , 
The above discussion demonstrates that the liver is concerned pri-
marily with the elimination of circulating steroids , If active steroids 
remained in the circulation for long periods of time, their circulating 
concentrations could not influence the moment-to-moment control of pitui-
tary LH and FSH secretion, However, through the action of the liver, 
active steroids have a relatively short half-life and rapid turnover 
rate, and thus testosterone or its metabolites can exert a high degree of 
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control over gonadotropin secretion . 
Brain and Anterior Pituitary 
The relationship between the anterior pituitary gland and the gonads 
has been investigated intensively since 1917 when Addison showed that 
basophilic cells in the pituitary gland increased in size and number with 
formation of granules in response to castration. By 1927, Smith demon-
strated that hypophysectomy caused testicular atrophy and that hypohy-
sectomized males receiving pituitary transplants exhibited a striking 
increase in testis weight as well as the ability to mate and to sire 
normal litters . These and other investigations permitted, Moore and Price 
(1932) to propose the concept that the gonads and the pituitary gland 
play upon each other toward the achievement of a balance of function . 
This hypophyseal-gonadal relationship has been referred to as "negative 
feedback" or "push-pull" . 
Soon after the demonstration of this reciprocal control of the 
pituitary-testicular axis, the first successful attempt to activat e the 
release of pituitary ovulating hormone by applying electrical stimuli to 
the brain was made by Marshall and Verney (1936) , They applied a 50-
cycle , 30 volt shock across the rabbit head and noted ruptured follicles 
24 hr later , Subsequently, a variety of experimental techniques and end-
points established the role of specific hypothalamic nuclei i n the regu-
lation of the synthesis and release of gonadotropic hormones from the 
anterior pituitary, For example, electrical stimulation of the hypo-
thalamic tuber and preoptic region provoked ovulation in rabbits (Harris, 
1937) , In addition, bilateral lesions immediately anterior and ventral 
to the paraventricular nucleus enhanced gonadotropin release in rats 
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(Hillarp, 1949). Subsequently, the dependence of the pituitary gland on 
the medial basal hypothalamus was shown by grafting pituitary glands in 
hypophysectomized animals (Harris and Jacobsohn, 1952) . Grafts placed 
under the median eminence, under the temporal lobe , or in the empty 
pituitary capsule became well vacularized, but only grafts under the 
median eminence acquired vascular connections with hypophyseal portal 
vessels , Importantly, only the animals with grafts under the median emi-
nence exhibited normal pituitary histology and gonadotropin secretion as 
judged by regular estrous cycles, pregnancy, and the production of live 
young , Harris and Jacobsohn concluded that the secretion of anterior 
pituitary hormones was under hypothalamic control, mediated by the 
hypophyseal portal circulation, 
Halasz,~~· (1965) termed the region in which grafts showed nor-
mal histology the "hypophysiotrophic area" of the hypothalamus . This 
area includes the entire arcuate nucleus, the ventral part of the anter-
ior periventricular nucleus, and the medial par t of the retrochiasmatic 
area. Halasz, et ~· concluded that neurons thr oughout t he hypophysio-
trophic area contain substances necessary for the secr etion of gonado-
tropins, although these substances are normally t r ansported to the median 
eminence and released into the hypophyseal portal circulation , 
Using a different technique, Lisk (1962) implanted crystall i ne 
steroids packed into barrels of hypodermic tubing and found that 
testosterone-filled implants in the arcuate nuc leus of male rats led t o a 
decrease in gonadal and accessory sex organ weight . The importance of 
the median eminence region in the male rat was demonstrated by using im-
plants of cyproterone, an antiandrogen (Bloch and Davidson, 1967) . This 
synthetic steroid blocks the retention of testosterone in androgen tar get 
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cells (Fang, et ~·, 1969). Based on the assumption that this was the 
principal action of cyprotereone in the brain, Bloch and Davidson rea-
soned that intracerebral cyproterone implants would decrease androgen 
accumulation in the hypophysiotropic region and thus stimulate pituitary 
gonadotropin release. They found that implants of cyproterone in the 
median eminence of immature male rats resulted in hypertrophy of the 
testes, seminal vesicles and prostate when compared to control rats 
implanted with cholesterol, 
In contrast to the above findings with hypothalamic steroid implants 
Bogdanove (1963) was able to inhibit castration cell formation by placing 
estrogen pellets in the pituitary gland of an ovariectomized female rat, 
The effects of pituitary estradiol implants were restricted to tissue 
around the pellet and the size of the affected area depended upon the 
amount of estrogen implanted, Bogdanove concluded that steroids from 
small implants in the pituitary would not reach a sufficient number of 
gonadotropin cells to affect significantly the function of the entire 
gland. However, implants placed in the median eminence are directly 
above the pituitary portal circulation and might diffuse into the portal 
circulation, thus perfusing the entire pituitary with steroids, Thus, 
implants in the hypothalamus may operate by release of the hormone into 
the hypophyseal portal vessels thereby acting at the pituitary level 
rather than the hypothalamic level, 
Smith and Davidson (1967) apparently solved the controversy of the 
inhibitory site of action for gonadal steroids by using animals with 
transplanted pituitaries. When they transplanted four pituitary glands 
to the kidney capsule of a male rat and several weeks later removed the 
animal's own pituitary, they found that in a small percentage of cases 
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the animals showed testicular maintenance indicating that some releasing 
factor reached the transplanted pituitary. In these animals, testoster-
one implants in the median eminence region resulted in a decrease of 
testicular weight, number of mature spermatozoa, and diameter of the 
seminiferous tubules, Smith and Davidson maintained that, in the case of 
testosterone, a direct effect of the hormone on the hypothalamus had been 
demonstrated. 
The controversy continued as Kingsley and Bogdanove (1973) used uni-
lateral intrapituitary implants of micropellets containing testosterone 
propionate, dihydrotestosterone benzoate, and a synthetic androgen 7a-
methyl-19-nortestosterone acetate in castrated males to show a reverse of 
castration cell development and an increased intrapituitary FSH :LH ratio 
(an action of systemically administered androgens) , The unilateral im-
plants did not affect the entire pituitary. Thus, Kingsley and Bogdanove 
concluded that their results showed a direct action of androgens on the 
pituitary, but they also stated that the question of where "physiological" 
amounts of gonadal steroids act to influence the gonadotrophic activity 
of the hypothalamic-pituitary unit remains unanswered , 
Since testosterone is the principal circulating androgen in males 
(Hall, 1970), evidence demonstrating that testosterone could be concen-
trated by cells in the brain and pituitary would provide evidence that 
gonadal steroids act at both sites, Dry-mount autoradiographs revealed 
that radioactive testosterone was selectively concentrated and retained 
in the hypothalamus, other limbic structures, and in the pituitary 
(Phaff, 1968) . Similarly, Sar and Stumpf (1973) found reduced silver 
grains, attributed to the uptake of radiolabeled testosterone over cell 
bodies of neurons in the preoptic area, arcuate and ventromedial nucleus, 
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the hippocampus, the amygdala as well as cells in the anterior pituitary 
gland. As a result of these studies, the consensus emerged that the 
brain and pituitary gland were able to concentrate radioactivity follow-
ing the injection of radiolabeled testosterone, but autoradiographic pro -
cedures do not permit the identification of localized radioactive 
molecules. An additional criticism of some studies utilizing autoradio-
graphy is the possibility of diffusion of radioactivity during fixation 
thus giving false localization of radioactivity, Therefore, following 
extraction and scintillation counting, radioactivity in the pituitary was 
found to be higher following estradiol injection than when testosterone 
was injected (Tveter, 1970), This demonstrates a differential uptake of 
these two steroids in the pituitary. Similar techniques were used to 
investigate the factors influencing testosterone uptake by a number of 
brain regions (McEwen,~~., 1970a, 1970b). The highest uptake was re-
corded in the pituitary gland followed by the hypothalamus, preoptic 
area, and septum. Hypophysectomy and cyproterone decreased, and castra-
tion increased uptake in the brain , More recently, Noess and Attr amadal 
(1974) found radioactivity bound to the macromolecules in the pituitary , 
hypothalamus, preoptic area, and the cerebral cortex after IM testost er-
one injection. All of the above authors did not characterize the r adio-
activity in any of the tissues. 
The demonstration that the conversion of testosterone to dihydro -
testosterone (DHT) in the prostate as a necessary step in the action of 
testosterone (Bruchovsky and Wilson, 1968) caused a number of investi -
gators to hypothesize testosterone metabolism could be a prerequisite fo r 
androgen action in regulating gonadotropin secretion by the pituitary 
gland, For example, Sholiton and Werk (1969) used in vitro incubations 
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of whole rat brains with [14c] testosterone to show metabolism to 
androstenedione, DHT, and a small amount of Sa- and SS-androsterone. 
Similarly, in a more definitive study, Jaffe (1969) found that minces of 
rat pituitary, hypothalamus, and cerebral cortex were capable of con-
verting [7- 3H] testosterone to androstenedione and DHT. The greatest 
conversion of testosterone to androstenedione and DHT, per mg of tissue, 
occurred in the pituitary. Jaffe concluded that pituitary luteinizing 
hormone secretion may be regulated by DHT acting alone or in combination 
with testosterone, 
Another in vitro investigation studied the localization of Sa-
reductase, 3a- and 3S-hydroxysteroid dehydrogenases in the brain and 
pituitary of the male rat (Rommerts and van der Molen, 1971) . They found 
that the hydroxysteroid dehydrogenases were present in the soluble frac -
tion while the Sa-reductase activity was localized in the microsomal 
fraction, The Sa-reductase activity, relative to the whole brain, was 
highest in the cerebellum followed by the hypothalamus and then the pitu-
itary , The function of this apparently higher Sa-reductase activity in 
the cerebellum was not determined. A study of some of the hormonal 
factors influencing the conversion of [14c] testosterone to DHT showed 
that testosterone decreased and castration increased the Sa-reductase 
activity in the pituitary glands of rats (Massa, et ~· , 1972) , This re -
port also implicated a role for FSH in modulating Sa-reductase activity 
but failed to show any effect of LH and ACTH. The conclusion that 
emerged from these studies is that the conversion of testosterone to DHT 
was probably necessary for initiating androgen-induced feedback in the 
pituitary gland, Jouan, ~~· (1973) studied the association of previ-
ously injected [3H] testosterone to macromolecules in nuclei isolated 
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from rat pituitary gland. Characterization of the radioactivity revealed 
that testosterone (66%) and a small amount of DHT (7%) were associated 
with the macromolecules, 
Another hypothesis explaining how androgens may influence the 
central nervous system is aromatization of androgens to estrogens. 
Androstenedione is readily aromatized to estrone by homogenates of ante-
rior hypothalamus but not posterior hypothalamus, pituitary gland or 
cerebral cortex (Naftolin, et ~., 1972). In addition evidence has been 
presented to show that the hypothalamus of males can aromatize twice as 
much androstenedione to estrone than that of females (Reddy, et ~. , 
1974) , Despite the evidence for aromatization developed in vitro, in-
jection of dihydrotestosterone (a reduced ring A compound which cannot be 
converted to estradiol (Ito and Horton, 1971) decreased LH in castrate 
male rats (Swerdloff, et ~., 1972). In view of the capacity of DHT to 
suppress pituitary LH secretion, aromatization of androgens to estrogens 
may not be the mechanism regulating gonadotropin secretion in males , 
However, comparisons of the efficacy of testosterone, DHT and estradiol 
to suppress pituitary LH release in castrate male rats revealed that 
estradiol was the most and testosterone the least potent of the three 
steroids tested (Verjans, et ~., 1974), Estradiol was more than 60 
times and DHT 4 times as potent as testosterone in inhibiting gonado -
tropin secretion in this model system, 
In summary, the above review points to the need to understand: 
(1) the site or sites (in the hypothalamus or pituitary gland or both) 
androgens act to inhibit gonadotropin secretion, and (2) in what form 
androgens act in these tissues. These two problems need to be resolved 
in order to understand the mechanism by which circulating testosterone 
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regulates pituitary gonadotropin secretion, 
Ventral Prostate 
Greer (1959) injected 100 pg of [4- 14c] testosterone and found a 
significant accumulation of radioactivity in the ventral prostate and 
seminal vesicles of male rats. The accessory sex glands retained ap-
preciably more radioactivity than muscle~ adrenal or salivary tissue, 
indicating a selective retention of androgen by these target tissues , In 
addition, Harding and Samuels (1962) studied the uptake and intracellular 
distribution of radioactivity in various tissues after injecting [4- 14c] 
testosterone IP into rats. The total radioactivity present in the ven-
tral prostate was only slightly higher than that in blood, but the con-
centration of radioactivity present in chloroform extracts of the 
prostate contained the majority of the radioactivity which was identified 
as androstenedione, These authors also found that blood and liver con-
tained a large amount of conjugated metabolites which were absent from 
the ventral prostate, suggesting that the prostate selectively accumu-
lated free but not conjugated metabolites of testosterone, 
3 
In 1968, Bruchovsky and Wilson described the metabolism of [1,2 - H] 
t estosterone following intravenous injection to normal and functionally 
hepatectomized male rats, These investigators obtained evidence, in bot h 
types of animals, that testosterone was taken up by the prostate within 
1 min after its administration and that at least 90% was converted to 3a-
androstanediol~ Sa-dihydrotestosterone (DHT) and androsterone. However, 
only tritiated testosterone and DHT were recovered from prostatic nuclei 
2 hr after testosterone injection. Moreover, the conversion of testos-
terone to DHT in various tissues of 11 species has been studied and the 
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highest rate of formation was found in the rat prostate (Gloyna and 
Wilson~ 1969) . These authors concluded that the formation of DHT is not 
an obligatory reaction for all of the effects of testosterone but is 
probably responsible for its cell proliferative effects in the prostate . 
Dihydrotestosterone~ androstenedione and 6S-hydroxytestosterone were 
present in prostatic tissue incubated with 3H-testosterone, demonstrating 
the presence of an oxidative pathway (Plasse,~ al.~ 1971). Comparison 
of the extent to which the prostate gland of castrate rats metabolized 
seven different androgens in vitro provided evidence for ~4 -Sa-reductase, 
3a-hydroxysteroid dehydrogenase and 17S-hydroxysteroid dehydrogenase in 
prostatic tissue (Bruckovsky, 1971). Similarly, incubation of testos-
terone in organ cultures of prostatic tissue permitted the isolation of 
DHT, both 3a- and 3S-androstanediol and androsterone (Robel, 1971) . No 
DHT was found after incubation of 3S-androstanediol, suggesting the irre-
versibility of 3S-hydroxysteroid dehydrogenase. Robel's studies sug-
gested the presence of two categories of testosterone metabolities: DHT 
and 3a- androstanediol being representative of one series, and 3S-
androstanediol typical of the second category. He concluded that these 
categories sustained the hypothesis that testosterone action is mediated 
by two kinds of metabolites, DHT controlling tissue growth and 3S-
androstanediol controlling secretion. 
3 Studies on the retention of H-DHT by a protein in prostate cell 
nuclei demonstrated that if prostate cell nuclei were first isolated from 
castrated rats and then incubated with testosterone or DHT, there was no 
retention of DHT in a protein-bound form (Fang,~~·~ 1969), However, 
upon addition of a cytosol fraction, the nuclear fraction was found to 
retain DHT. Along similar lines, Fang and Liao (1971) described two 
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cytoplasmic proteins capable of binding DHT, but only one of these DHT-
protein complexes was accepted by the nucleus. Thus, Liao and his 
associates, as well as numerous other investigators, proposed a scheme fo r 
the action of androgens on the prostate, In this scheme, testosterone or 
other androgens are accumulated by the prostate, converted to DHT which 
in turn is bound to one or more cytoplasmic proteins . The DHT-protein 
complex is then available to bind to the nucleus and thus initiate part 
of the androgen action on the prostate, 
The prostate gland was included in the present investigation because 
testosterone metabolism has been studied extensively in this tissue and 
it was believed that the prostate gland could serve as a model for 
studies aimed at elucidating the uptake, retention and metabolism of 
testosterone following in vivo infusion of [3H] testosterone , 
Testis 
The rat testis metabolizes testosterone in vi t ro to Sa-androstane-
3a , 17S- di ol ; SS-androstane- 3a, 17S-diol; Sa-androstane-36, 176-diol; 
16a-hydroxytestosterone; 114 , 16-androstadiene-3- one, and 1116-andr osten-
36 -ol (Stylianou, et ~, , 1961) , Detection of these metaboli t es suggests 
the presence of Sa- and 56-reductase, and 16a-hydroxylase , Moreover , 
Nayfeh and Baggett (1966) found considerable (8-40% ) conversion of 14c 
progesterone to 3a- androstanediol implying that testicular t i ssue can 
synthesize testosterone from progesterone and then metabolize this 
androgen to Sa- reduced products , 
To assess the localization of testosterone metabolites within the 
testis, incubation of isolated segments of interstitial tissue and semi-
niferous tubules with [14c] testosterone demonstrated that the tubules 
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formed 3a-androstanediol with a small amount of dihydrotestosterone (DHT) 
and androstenedione. On the other hand, androstenedione was the predomi-
nant metabolite in the interstitial tissue (Rivarola and Podesta, 1972). 
The physiological role for the conversion of testosterone to andro-
stenedione in the interstitial tissue was not known, Similar findings 
were reported by Derrington and Fritz (1973) with 3a-androstanediol being 
the major metabolite of [14c] testosterone in the seminiferous tubules 
and DHT the major metabolite in a cellular suspension of spermatocytes. 
The implication inherent in these results is that spermatocytes may re-
semble other androgen responsive tissues from the standpoint of metabo-
lizing testosterone to one or more Sa-reduced products. 
In an extensive study of androgen metabolism in the rat testis, 
Sowell, et ~· (1974) used both in vivo and in vitro techniques. Follow-
ing the subcutaneous injection of 100 ~Ci of [3H] testosterone, the con-
centration of radiolabeled testosterone was always higher in blood than 
testis whereas [3H] DHT and [3H] 3a-androstanediol concentrations were 
always higher in the testis than blood. In addition, testes of immature 
animals formed significantly more Sa-reduced androgens including 3a- and 
3S-androstanediol and androsterone than testicular tissue from mature 
animals after in vitro incubation with [3H] testosterone. Localization 
of the hydroxysteroid dehydrogenases was shown when incubation of [3H] 
DHT with seminiferous tubules produced primarily 3a-androstanediol while 
3 interstitial tissue produced 3S-androstanediol. When [ H] 3a-
androstanediol was incubated with either seminiferous tubules or inter-
stitial tissue the principal metabolite was androsterone, indicating that 
17S-hydroxysteroid dehydrogenase was present in both testicular compart-
ments. Evidence indicating that testosterone was converted to DHT 
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by seminiferous tubules was confirmed, and extended to show that the 
quantities of DHT and 3a-androstanediol produced by the seminiferous 
tubules increase in proportion to the concentration of testosterone in 
the incubation media (Lloret and Weisz, 1974). This result suggests that 
the intratubular concentration of testosterone may play a role in modu-
lating the intratubular level of DHT. 
Recently, Derrington and Fritz (197S) have localized two of these 
enzymes to two cellular preparations from the testis. The spermatocyte-
enriched preparations contain Sa-reductase while the Sertoli cell-
enriched preparations contain some Sa-reductase and a high level of 3a-
hydroxysteroid dehydrogenase. Testosterone conversion to Sa-reduced 
metabolites in the testis may be of paramount importance since receptors 
for androgens (androgen binding protein and a "cytoplasmic receptor") 
have been postulated to be required for the mediation of the androgen 
stimulus to the germ cells (Hansson,~ al., 1974; Means,~~., 197S), 
Aromatization of androgens to estrogens may be an important mechan-
ism regulating testis function since estradiol was shown to be produced 
in seminiferous tubules and localized in the interstitial tissue (deJong, 
et ~., 1974), Confirmation of this localization and the demonstration 
that estradiol binds to a so called "receptor" in interstitial tissue im-
plies that the cells of the seminiferous tubules might communicate with 
interstitial cells by secreting estradiol and thus provide a regulatory 
signal for interstitial cell function, 
The review of testicular testosterone metabolism illustrates two 
important reasons for assessing in the present study the extent to which 
the testis metabolizes testosterone, First, the in vitro data demon-
strates that the testis contains Sa-reductase and aromatizing enzymes 
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that can lead to the production of two metabolites, DHT and estradiol, 
respectively, that are believed to play regulatory roles in sperm pro-
duction, Secondly, since testosterone increased DHT and 3a-
androstanediol formation in vitro, the effect of testosterone-filled 
Silastic implants on testosterone metabolism needs to be studied follow-
ing the in vivo administration of [3H] testosterone because of the 
effects this treatment can have on the testis. 
Steroid Diffusion Through Silicone Rubber 
Dzuik and Cook (1966) were the first to demonstrate that hormonal 
steroids diffuse through polydimethylsiloxane (Silastic) capsules at 
relatively constant rates, Since their initial observation numerous 
steroids, including testosterone, have been shown to pass through silastic 
tubes either in vivo or in vitro at a fairly constant rate for extended 
periods of time (Kincl, et ~., 1968; Moon and Bunge, 1968; Reddy and 
Piasal, 1973; Berndtson, ~ ~,, 1974), 
Kincl, et ~, (1968) proposed that steroid diffusion through Silastic 
capsules was inversely proportional to wall thickness and directly pro-
portional to the surface area of the implant. Comparisons of the 
efficacy of administering hormonal steroids via subcutaneous injection, 
oral administration, and subdermal Silastic implants revealed that 6 to 
25 times less megestrol acetate was needed to produce comparable bio-
logical effects when administered via a Silastic implant (Chang and 
Kincl, 1968), A subsequent investigation showed testosterone-filled 
Silastic capsules were 15 to 30 times more effective than a daily injec-
tion of an oily solution of testosterone (Chang and Kincl, 1970), Enough 
testosterone was released through the wall of the Silastic capsules 
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during a 16 wk period to maintain the accessory sex glands of mature 
castrate rats (Moon and Bunge, 1968), More recently, Reddy and Prasal 
(1973) found a significant decrease in testicular weight and a slight in-
crease in seminal vesicle and prostate weight when male rats received 
130 ~g testosterone per day via a subdermal Silastic capsule, 
Comparison of the capacity of various androgens to inhibit or main-
tain spermatogenesis in rats established that a 200 mm2 testosterone-
filled Silastic capsule decreased testicular weight by 40 to 50% during a 
56 day interval (Berndtson, ~~., 1974). The decline in testis weight 
was accompanied by an eight-fold drop in serum LH and FSH concentrations 
even though plasma testosterone titers and the dry weight of the accessory 
sex glands were not affected by the testosterone released from 200 mm 
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capsules, Two possible mechanisms were suggested to explain how 
apparently normal blood levels of testosterone could inhibit pituitary 
gonadotropin release, First, androgens released from Silastic capsules 
could be converted to another hormonal steroid which inhibits gonadotropin 
secretion. Secondly, episodic increase in testosterone secretion may 
have been attenuated and replaced by the steady release of testosterone 
from the Silastic capsule which could be more efficient for inhibiting 
gonadotropin release than the normal fluctuating plasma testosterone 
levels, 
Thus, testosterone is released from Silastic capsules at a constant 
rate, and a 200 mm2 implant is capable of maintaining testosterone titers 
near normal yet cause a decrease in testis weights and serum LH and FSH 
levels. Although a variety of studies are still needed to establish the 
efficacy and safety of the use of Silastic capsules in man, this approach 
shows sufficient promise as a possible male contraceptive to warrant 
investigation into the metabolism of testosterone in the testosterone 
treated rat, 
Steady State and Infusion Techniques 
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Radioactive molecules are assumed to behave chemically and physio-
logically exactly like their natural counterparts except for slight ef-
fects due to differences in mass, When radioactive molecules are admin-
istered to animals the mass of the radioactive molecule can be very small 
in comparison with the mass of the endogenous .molecule. As a result 
radioactive materials have several potential uses in the intact animal, 
One of these is .to identify metabolic pathways by which a radioactive 
precursor is converted to a radioactive product, In such experiments, 
the animal body may be viewed as an assortment of pools or compartments, 
defined by both the species (compound, ion, etc.) and the space in which 
it is distributed, Thus; two different compounds distributed in the same 
space or one compound distributed in two spaces are considered to be two 
different pools (Gurpide, ~~., 1963), 
One method of introducing a radioactive molecule into an animal is 
via constant intravenous infusion, Immediately after starting the in-
fusion of a tracer, the concentration of the infused hormone in the blood 
increases until a steady state is reached, As the specific activity of 
the infused material increases, the amount of radioactivity removed from 
the circulation also increases since the total rate of removal of the 
compound is assumed to be constant. After some length of infusion, the 
rate of exit of the labeled compound approximately equals its rate of 
entry into the circulation, and an isotopic steady state is established 
(Gurpide, 1971), Thus, by studying the distribution of tritiated 
testosterone and its labeled metabolites while the animal is in an iso-
topic steady state, the results obtained will more closely mimic the 
metabolism of endpgenous testosterone, 
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Several assumptions underly a steady-state condition: (1) stable 
incorporation of isotopic atoms in the tracer; (2) complete mixing of 
labeled and unlabeled material in each metabolic pool, and that this 
mixing is rapid in comparison with the rates of transfer of material be-
tween the pools; (3) the negligible amount of labeled material added to 
any pool in comparison to the size of the compartment; (4) all rates of 
metabolism and production of a hormone remain constant during the experi-
ment; (5) nq changes .in the concentration of the compound either in the 
blood or in the tissues; and (6) identical metabolism of the administered 
tracer and endogenously produced compound (Gurpide, ~~,, 1963; 
Gurpide, 1971), 
With these assumptions in mind, the infusion technique still has the 
advantages of: (1) establishing equilibrium between all metabolites; (2) 
giving a precise estimate of the tissue hormonal pool; (3) maintaining 
the relative concentrations of metabolites within the tissue; and (4) not 
changing the relative level of accumulation from one tissue to another as 
occurs following a single injection of tracer (Tait and Horton, 1966; 
Gurpide, 1971), 
Infusion and steady-state kinetics have been primarily used to 
assess the rate of conversion of one compound to another, estimate 
metabolic clearance rate, and establish hormone production and secretion 
rates, Since the use of a constant infusion technique has been rela-
tively ignored in investigations of testosterone metabolism, one of the 
objectives of the present study was to assess the validity of using 
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continuous infusion to detect changes in testosterone metabolism in ani-
mals exposed to different androgen levels, 
Summary 
The preceding review has demonstrated that testosterone diffuses 
through subdermal Silastic capsules at predictable rates and illustrates 
the advantages and potential usefulness of the constant infusion tech-
nique for studying androgen metabolism in vivo, In addition, the extent 
to which testosterone is accumulated and retained by a variety of tis-
sues (brain, pituitary, testis, liver and prostate) has been discussed. 
Comparison of the uptake and retention of testosterone illustrates that 
(1) hepatic testosterone metabolism is primarily reductive and oxidative 
and may be easily modified by the hormonal mileau; (2) the prostate con-
verts testosterone to dihydrotestosterone which is responsible for the 
transcriptional and translational action of androgens in this tissue; (3) 
the testis metabolizes testosterone to 5 -reduced products and estrogens 
which may be involved in intratesticular regulation of spermatogenesis; 
and (4) the brain and pituitary may metabolize testosterone to affect 
regulation of gonadotropin secretion, 
To gain a better understanding of the relationship between circu-
lating testosterone levels and the regulation of gonadotropin secretion, 
the following must be determined: (1) testosterone release rate from 
Silastic capsules and its effect on seminal vesicle weight; (2) the 
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validity of using continuous infusion to assess [ H] testosterone reten-
tion and metabolism and (3) where and in what form testosterone acts in 
the brain and pituitary gland to control gonadotropin secretion, 
CHAPTER III 
MATERIALS AND METHODS 
Materials 
Animals 
Male albino rats (300 to 400 g and 2 1/2 to 3 1/2 months old) were 
used in this study. They were raised in the laboratory from animals 
originally obtained from the Holtzman Co., Madison, Wisconsin. 
Silicone Rubber 
Polydimethylsiloxane capsules were prepared from Dow-Corning medical 
grade Silastic tubing (cat, no. 602-305) (0,6 mm wall thickness, 1.98 mm 
i,d,, 3,18 mm o,d,; 1 mm long= 10 mm2) and sealed with Dow-Corning 
Medical Adhesive Silicone type A. 
Infusion Materials 
Tubing, Clay Adams (New York, N.Y.) Intramedic Polyethylene tubing 
PE 20 (0.381 mm i.d. and 1.09 mm o.d.) and PE 100 (0,864 mm i.d. and 
1,52 mm o.d,) were used in preparing the indwelling catheter and 
connecting tubing. 
Pump, An Infusion-Withdrawal Pump, Model 600-900 (Harvard Apparatus 
Co., Millis, Mass,) was used to infuse radioisotope at a constant rate, 
31 
32 
Restraining Cage, A restraining cage for the rats was constructed 
from two plastic jars with the bottoms cut out. One was large-mouthed 
(tail-end) with an opening cut in the cap for the rat's tail. The other 
plastic jar was small-mouthed (head-end) and uncapped for the animal to 
breathe. The two jars were of slightly different diameters, allowing the 
open bottom of one jar to slide inside the other. thus permitting the 
cage to be adjustable to the length of the animal. The plastic jars were 
held in place around the animal by tape on the outside. 
Nonradioactive Steroids 
Testosterone (see Appendix A for abbreviations and systematic names), 
estrone. estradiol. androstenedione, epitestosterone. and ss-
androstanediol were purchased from s,teroloids. Inc,, Pawling, N, Y, Sa-
and SS-dihydrotestosterone, androsterone, Sa- and SS-androstanedione, 3a-
and 3S-androstanediol, Sa- and SS-epiandrosterone were obtained from 
Sigma Chemical Co., St. Louis, Missouri, 
Steroid Derivatives 
Acetates, Testosterone acetate, Sa-dihydrotestosterone acetate, 
estrone acetate. estradiol acetate, androsterone acetate, and 3a-
androstanediol acetate were purchased from Steraloids. Inc., Pawling, 
N.Y. and stored at SCat a concentration of 1 mg/ml in benzene:ethanol 
(9: 1). 
Methoximes, Methoxime derivatives of androstenedione and Sa-
androstanedione were prepared in the laboratory (see Methods). 
Derivatization Compounds 
Pyridine (Matheson, Coleman and Bell, Baton Rouge, La,), acetic 
anhydride (Fisher Scientific Company, Fairlawn, N.J.) and methoxyamine 
hydrochloride (Eastman Kodak Co., Rochester, N,Y,) were stored at room 
temperature in a desiccator over calcium chloride, 
Scintillation Counting Material 
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Scintillation counting was performed in 12 ml of toluene (Beckman) 
Instruments, Inc,) based scintillation fluid containing 0.004% p-bis-2-(5 
phenyl-orazoyl) benzene (POPOP) and 0.4% 2,5-diphenyloxazole (POP) (New 
England Nuclear, Boston, Mass.). The mixture was allowed to equilibrate 
at least 24 hr before use and stored in the dark. 
Reagents 
The nanograde solvents (Mallinckrodt Chemical Works, St. Louis, Mo.) 
included acetone, benzene, chloroform, ether, ethyl acetate, hexane and 
methanol. Methylene chloride was purchased from Burdick and Jackson 
Laboratories (Muskegon, Mich.) and ethanol was obtained from Commerical 
Solvents Corp, (Harvey, La,), All solvents were fractionally distilled 
through a column packed with glass helices (1/4 in i,d,, Scientific Glass 
Apparatus Co,, Bloomfield, N.J.) just prior to use. Methanol was frac-
tionally distilled over 2,4 dinitrophenylhydrazine and sulfuric acid 
(Haltmeyer and Eik-Nes, 1972). The methanol distillate was stored under 
N2 at 4 C and fractionally redistilled prior to use. Water used in the 
procedures was distilled and filtered through two filters (Continental 
Water Supply, Austin, Texas). The filters included an activated charcoal 
filter to remove organic material and a combination anionic-cationic 
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resin filter to remove minerals and ions, 
Glassware 
Immediately after use, glassware was rinsed, soaked in detergent for 
24 hr, and placed in dichromate-sulfuric acid solution overnight, Fol-
lowing ten tap water rinses, the glassware was soaked in detergent, 
rinsed again with tap water and placed in dilute hydrochloric acid, The 
24 hr acid bath was followed with rinses as follows: ten times with tap 
water, ten times with deionized water and two times with fractionally 
distilled methanol, The glassware was subsequently air dried at room 
temperature, 
Chromatographic Materials 
Adsorbents, Silica gel (Silica TLC-7GF, Mallinckrodt) plates (20 em 
x 20 em) were poured (0.25 mm thick) from a slurry of 24 g silica gel in 
64 ml water. Aluminum oxide (Merck 1101, neutral type T) plates (20 em x 
20 em) were prepared (0,25 mm thick) from a slurry of 60 g aluminum oxide 
in 84 ml water. 
Development. Thin layer plates were developed in rectangular tanks 
lined with Whatman 3M (W, R. Balston, Ltd,, England) filter paper, 
Solvents were allowed to equilibrate for at least 1 hr. 
Visualization Spray. Primulin (Pfaltz and Bauer, Inc,, Flushing, 
N,Y,) at 0.002% in acetone:water (4:1) was used to detect reference 
steroids. 
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Radioactive Isotopes 
[1,2,6,7- 3H] testosterone (85-100 Ci/mM), [7-3H] testosterone (25 
Ci/mM), [4-14c] testosterone (57.5 mCi/mM), [1,2- 3H] dihydrostestosterone 
(40 Ci/mM), [4-14c] dihydrostestosterone (50.6 mCi/mM), [2,4,6,7- 3H] 
estradiol-1713 (52 mCi/mM), [2,4,6,7-3H] estrone (106 Ci/mML [4-14c] 
estrone (58.2 mCi/mM), [1,2- 3H]-androsterone (40 Ci/mM), [1,2-3H]Sa-
androstan-3a,l7S-diol (44 Ci/mM), and [4- 14c] androstenedione (50 mCi/mM) 
were purchased from New England Nuclear, Boston, Mass. 
Since [14c]Sa-androsterone and [14c]Sa-androstanedione were not 
available commercially, these compounds were synthesized from [ 4- 14c] 
testosterone (see Methods). 
Solution for Tissue Homogenization 
The solution used for homogenization of tissues was prepared by 
mixing 109.539 g sucrose (0.32 M), 0.2033 g MgC1 2 ·6H20 (0.001 M), 
0.1109 g CaC1 2 (0,001 M) and 0.1361 g KH2Po4 (0.001 M) in 1 liter of dis-
tilled water. This buffered sucrose solution was adjusted to pH 6.5 and 
stored at 5 C. 
Methods 
Animal Housing and Preparation 
The rats used in this study were housed in groups of four or five 
per cage in an air-conditioned (22 ± 2 C) room on a 14:10 hr light:dark 
schedule and provided with Wayne Lab Blox (Texas Feed and Ranch Supply) 
and water ad libitum. Castration and subcutaneous implantation of 
testosterone-filled Silastic capsules were performed under light ether 
anesthesia, 
Polydimethylsiloxane Capsule Preparation 
and Implantation 
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Silastic (Dow-Corning) medical grade silicone rubber tubing was used 
to prepare all capsules. The tubing was rinsed with hot tap water, dis-
tilled H2o, and air dried. The desired length of tubing (30 mm) was cut, 
one end sealed with approximately 3 mm of Silicone Medical Adhesive type 
A and allowed to cure at room temperature for 24 hr. Silastic tubing 
with one end sealed and cured was filled to 20 mm with chromatographically 
pure crystalline testosterone, The remaining end was sealed with Silicone 
Medical Adhesive type A and cured as previously described. The sealed 
ends were trimmed to 2 mm. The capsules were then rinsed in ethanol and 
dried at 55 C for 24 hr, 
After weighing to the nearest 1/lOOth of a mg, the capsules were 
placed subcutaneously along the dorsal midline of the rats. Testosterone 
release rate (~g/day) was determined by subtracting post-implantation 
weight from pre-implantation weight of the silastic capsule, 
Recrystallization of Nonradioactive 
Steroids 
Nonradioactive steroids were recrystallized by placing 100-1000 mg 
of the desired steroid in a minimal volume of aqueous methanol (70%) 
(Axelrod, et ~·~ 1965), The tube containing the dissolved steroid was 
allowed to come to room temperature for 2 hr, followed by 5 hr at 5 C and 
then 12 hr at -20 C. The methanolic solution was removed and the tube 
containing the crystals was placed in a vacuum jar containing phosphorus 
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pentoxide and dried for 72 hr, The crystals were transferred to a screw 
cap vial and stored at 5 C, Standard solutions of the 15 nonradioactive 
steroids were made at a concentration of 1 mg/ml in either 
benzene:ethanol (9:1) for androgens or in ethanol for estrogens and 
stored at 5 C. These solutions were checked periodically for chromate-
graphic purity using separate solvent systems described below. 
Preparation of [4- 14c]5a-androstanedione 
14 
and. [ 4- C] -androsterone 
Carbon labeled 5a-androstanedione and androsterone were synthesized 
by a procedure adapted from Ota, et aL (1972). Briefly, 0.5 g of liver 
from an adult female rat was homogenized in 3 ml of 0,1 M Krebs-Ringers 
phosphate (KRP) buffer (pH 7,4). The homogenate was incubated with 
14 [4- C] testosterone and 500 ~g NADPH (dissolved in 0.5 ml 0,1 M KRP) for 
60 min at 37 C in an atmosphere of 95% o2 :5% co2• [14c]5a-androstanedione 
and [14c] androsterone were extracted, isolated and purified by the pro-
cedures described below. 
Preparation of Indwelling Catheters and 
Connecting Cannulas 
The indwelling catheter (PE 20, 15 em long and beveled at one end) 
was prepared by bending the tube around a 0.5 em steel rod in boiling 
water to conform to the shape of the animal, Three cuffs (PE 100, 1 em 
long and flared at both ends) were enlarged by forcing on a 19 gauge 
needle and dipped in boiling water. The cuffs were arranged on the 
catheter to facilitate anchoring the catheter to the surrounding muscula-
ture and to allow approximately 1 em of the beveled end to be introduced 
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into the jugular vein, Cuffs were made stationary on the catheter by 
flaring slightly. The connecting tubing (PE 20, 35 em long) was encased 
in a small, hollow steel spring to prevent the animal from chewing 
through the tubing. A different indwelling catheter and connecting 
tubing was used for each animal. 
Surgical Procedure 
Animals were anesthetized with ketamine hydrochloride (Ketalar, 
Parke Davis and Co., Detroit, Mich~, 60 mg/kg IM) followed 5 min later by 
sodium pentobarbital (Nembutal, Abbot Laboratories, North Chicago, Ill., 
21 mg/kg IP) (Youth,~~., 1973), The combined use of ketamine and 
pentobarbital sodium was found to be safe and rapid, and yet maintained a 
state of deep surgical anesthesia for at least 1 hr. 
Following clipping of hair from the back of the neck and over the 
left jugular vein, the skin was incised transversely between the shoulder 
blades and longitudinally over the jugular vein. Approximately 1 em of 
the jugular vein was exposed by blunt dissection, The salivary glands 
and subcutaneous tissue 1 to 2 em cephalad on the midline were freed to 
allow later placement of the U-portion of the cannula. A trocar (made by 
cutting the hub off a 6 in, 13 gauge hypodermic needle) was passed subcu-
taneously, starting at the midline of the neck, posteriorly, then around 
the left foreleg to the back skin incision, The cannula was inserted 
into the trocar and the trocar removed. The cannula was attached to the 
connector tubing and filled with isotonic saline using a 1 ml syringe, 
The vein was raised slightly, cut with iris scissors, and the cannula 
introduced to a distance of 1 em. The cannula was anchored to the neck 
muscles by suture around the cuffs and the incision closed, The back 
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skin incision was closed around the adaptors attaching the cannula to the 
connector tubing. The animal was placed in the plastic restraining cage 
and infused with isotonic saline (0.3 ml/hr) until recovery from 
anesthesia was complete (approximately 2 1/2 hr), 
Infusion of Radiolabeled Testosterone 
Following purification and purity verification, the isotope to be 
infused was diluted to a stock concentration of 1 1-1Ci per 10 ]Jl. Each 
animal was infused at a rate of 3.5 ]JCi/hr/100 g body weight. The cor-
rect volume of stock solution was placed in a small tube, evaporated to 
dryness, and resuspended in 2.5 ml of a 5% ethanol-saline solution. Two 
10 1-11 aliquots were taken and counted after addition of scintillation 
fluid. The infusion rate was determined by converting cpm of this known 
volume to ]JCi/hr, assuming the pump rate was constant. The remaining 
infusate was transferred to a 3 ml syringe and attached to the connecting 
tube. An initial infusion of 0.6 ml (0,3 ml equivalent to approximately 
12% of the total dose plus 0.3 ml of dead space in the connecting tube 
and catheter) was quickly administerd to the animal. All animals were 
infused at a rate of 0,5 ml/hr. The calibration and consistent rate of 
the Harvard Pump are shown in Table I. 
Tissue Collection and Homogenization 
At the end of the infusion the animal was anesthetized with ether, 
removed from the restraining cage, and the connecting tube removed. The 
chest cavity was opened and approximately 10 ml of blood was collected in 
heparin (1 mg) by heart puncture and stored on ice. The animal was per-
fused with 50 ml cold 0.85% saline via the left ventricle. The right 
40 
TABLE I 
CALIBRATION OF HARVARD INFUSION PUMP (SERIES 900) 1 
Time Interval Radioactivity (dpm) Delivered/ 11l/Time 111/hr (minutes) Time Interval Interval 
0- 19 26810 156 468 
20- 39 27278 158 474 
40- 59 28208 164 492 
60- 79 26003 151 453 
80- 99 28270 164 492 
100-119 29200 170 510 
120-139 28160 164 492 
140-159 28535 166 498 
160-179 29537 172 516 
180-199 29417 171 513 
200-219 29132 169 507 
220-239 30118 175 525 
495±6 .152 
1Calibrated by placing [1~2~6~7- 3H]-testosterone (17~177 dpm/100 111 
5% ethanol-saline) in 3 m1 B-D Luer-Lok glass syringe and pumping through 
50 em polyethylene tubing (Intramedic Clay-Adams PE 20) into a scintilla-
tion vial, 
2Mean ± standard error of the twelve time intervals. 
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atrium was cut allowing almost all blood to be drained from the animal, 
The prostate, seminal vesicles, brain, anterior pituitary, testes, and a 
portion of liver were removed and placed in a beaker of cold saline, All 
tissues were blotted slightly and weighed to the nearest 1/lOOth of a mg. 
A portion of the ventral prostate was separated from the other lobes and 
weighed, The testes were weighed, and the left testis was decapsulated 
and a portion of the parenchyma weighed. The other testis was placed in 
an oven for 48 hr at 50 C to obtain a dry weight, Dry weight of the 
testes (right = r and left = t) was determined by the following formula: 
Dry weight of testes 
(r + t) 
Dry weight Wet Weight 
= of testis (r) x of testes (r + t) 
Wet weight of testis (r) 
After the expression of fluid, both seminal vesicles were weighed, 
dried and reweighed, The brain was dissected according to McEwen and 
Pfaff (1970) to obtain samples of hypothalamus and cerebral cortex. 
Heparinized blood was centrifuged at 1500 rpm for 15 min at 5 C to obtain 
plasma. 
Tissue samples were placed in ice cold glass homogenizing tubes (80 
ml), Buffered sucrose solution was added to give a minimum of either 4 
ml of homogenate (including a wash of the homogenizing tube) or a concen-
tration of 50 mg/ml, Tissue homogenates and plasma were added to 80 ml 
extraction tubes containing each of the nonradioactive standards (50 ~g), 
and 14c radioactive standards (5000 dpm) that were isolated to minimize 
and correct for losses incurred in the isolation of 3H metabolites of 
testosterone. 
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Extraction of Testosterone Metabolites 
Plasma and tissue homogenates were extracted three times with 12 ml 
of dichloromethane, and the combined extracts evaporated under nitrogen 
at 45 C. The residue was dissolved in 15 ml of hexane and partitioned 
five times between 10 ml of 70% aqueous methanol. The combined dichloro-
methane extracts were evaporated under nitrogen and the residue concen-
trated to the tip of the tube with benzene:ethanol (9:1) (Table II). 
Separation of Testosterone Metabolites 
£l_ Thin-Layer Chromatography (TLC) 
The overall scheme of the thin-layer chromatographic procedures used 
to separate 14 metabolites of testosterone from tissue extracts is shown 
in Figure 2. The residue remaining after extraction was chromatographed 
on silica-gel and developed twice in dichloromethane:ether (85:15). Ad-
sorbent from all the zones shown in Figure 2 was scraped and aspirated 
into a disposable pipette packed with glass wool and eluted with warm 
benzene:ethanol (9:1). Appropriate standards were spotted on a single 
lane that was sprayed after chromatography with primulin and viewed 
under long- and short-wave ultraviolet light (UV), Characterization of 
the materials visualized under UV light in the five zones from the first 
TLC plate was as follows. 
Zone 1 contained radioactivity possibly associated with SS-
androstanediol (RF = 0.21}. This zone was scraped from the plate, eluted 
and rechromatographed on aluminum oxide and developed twice in dichloro-
methane:ether (9:1) (~ = 0.09). 
Zone 2 contained radioactivity possibly associated with testosterone 
epitestosterone, 3a.- and 3S-androstanediol. The respective RF values 
TABLE II 
VERIFICATION OF PROCEDURES USED TO EXTRACT AND ISOLATE 
TESTOSTERONE AND SOME OF ITS METABOLITES 1 
dpm Homog- Prostate Steroid Added Water enizing Homog-Solution en ate 
(1,2- 3H] Androstanediol 27,331 54.6 56.7 62,7 
±4.9 ±0.6 ±5.3 
3 [1 ,2.., HJ Androsterone 28,998 67.2 60.8 62.7 
±1.6 ±4.7 ±1.8 
(4-14C] Androsterone 4,926 57.6 
±1.6 
[4-14C] Androstenedione 27' 115 80.3 79.0 80.0 
±5.1 ±2.2 ±0.1 
[1,2- 3H] Dihydrotestosterone 19,965 75.3 73.4 78.0 
±0.4 ±6.4 ±3.1 
(4-14C] Dihydrotestosterone 3,260 74.2 
±2.5 
3 [2,4,6,7- H] Estradiol 28 '722 67,9 51.4 68.9 
±0.2 ±4,0 ±1.2 
[4-14C] Estradiol 3,820 64.2 
±3.5 
3 (2,4,6,7- H] Estrone 28,763 51.4 58,0 64.3 
:t6.5 ±2.8 ±0.9 
[4-14C] Estrone 4,919 57.6 
±2.5 
3 [ 1, 2, 6, 7- H] Testosterone. 24,529 75.9 73.9 76.3 
±4.0 ±5.3 ±3.4 
(4-14C] Testosterone 1,963 71.4 
±2.7 
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Plasma 
54.0 
±0.4 
60.7 
±Ll 
55.4 
±2.7 
76.2 
±3.1 
70.2 
±0.1 
66.3 
±4,4 
67.9 
±1.2 
54.5 
±L9 
55.4 
±4,4 
57.1 
±4.6 
75.7 
±1.9 
66.7 
±3.8 
1Values are mean percent recovery ± standard error of five determi-
nations. 
Figure 2, Thin Layer Chromatography Systems Used to Separate Testoster-
one and Some of its Metabolites. (Dash following the · ,, 
steroid abbreviation indicates separation, for systematic 
name see Appendix.) 
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were 0.43J 0.40J 0.37J and 0.32. The entire zone was scrapedJ eluted and 
rechromatographed on silica gel and developed in benzene :acetone (8: 2). 
This system allowed separation of 38-androstanediol (RF = 0.30)J 3a-
androstanediol (RF = 0.38) and a zone containing both testosterone (RF = 
0.48) and epitestosterone., The later zone was rechromatographed on 
aluminum oxide and developed twice in dichloromethane:ether (9:1). Tes-
tosterone (RF = 0.37) was adequately separated from epitestosterone 
(~ = 0.20). 
Zone 3 contained radioactivity possibly associated with estradiolJ 
58-dihydrotestosterone. 5a-epiandrosteroneJ androsteroneJ 58-
epiandrosteroneJ and 5a-dihydrotestosterone. The respective RF values 
were 0.56J 0.57J 0.59J 0.63J and 0.64. The entire zone was,scrapedJ 
eluted and rechromatographed on aluminum oxide and developed twice in 
dichloromethane:ethylacetate (80:20). Five distinct zones were formed 
in this system. The zones were associated with estradiol (~ = 0.29)J 
androsterone (RF = 0.49). both 58-dihydrotestosterone and 5a-
epiandrosterone (both RF values were O.S6)J 5a-dihydrotestosterone (RF = 
0.64 and a zone containing 58-epiandrosterone (~ = 0.71). 
Zone 4 contained radioactivity possibly associated with androstene-
dione (RF = 0.71). This zone was scrapedJ eluted and rechromatographed 
on aluminum oxide and developed twice in dichloromethane:ether (9:1) 
(RF = 0.63). · 
Zone 5 contained radioactivity possibly associated with 58-
androstanedioneJ estrone and Sa-androstanedione. The respective RF 
values were 0.84. 0.86. and 0.88. The entire zone was scrapedJ eluted 
and rechromatographed on aluminum oxide and developed twice in dichloro-
methane:ether (9:1). Three zones were evident in this system: one 
associated with estrone (~ = 0.48), another with SB-androstanedione 
(~ = 0.70) and finally one associated with Sa-androstanedione (RF = 
0.79). 
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Preliminary determinations showed that the majority of the uncon-
jugated radioactivity was associated with SB-, 3B- and 3a-androstanediol 
testosterone, estrone, androsterone, Sa-dihydrotestosterone, androstene-
dione, estrone and Sa-androstanedione. Thus only those steroids indi-
cated in Figure 2 by a dash after the name of the steroid were examined 
for radioactive purity. Each steroid was eluted from the final plate and 
concentrated to the tip of the tube. An aliquot of each steroid from the 
seven tissues of one animal was pooled for proof of purity by derivative 
formation (Table III). The remainder was assayed for radioactivity by 
liquid scintillation counting. 
Derivative Formation 
Steroids containing hydroxyl-groups were acetylated using a mixture 
of pyridine:acetic anhydride (5:1) (Dominquez,~~., 1963). Pooled 
aliquots of tentatively identified steroids of radioactive (10,000 dpm) 
plus nonradioactive (50 ~g) steroid standard were added to a 15 ml coni-
cal tube and concentrated with benzene:ethanol (9:1) under nitrogen at 
45 C. Following evaporation to dryness, 0.2 ml of acetylation mixture 
was added to each tube. Tubes were mixed with a Vortex mixer, capped, 
and the reaction allowed to proceed in the dark at room temperature for 
24 hr. The reaction was stopped by adding five drops of water and the 
mixture extracted three times with 2 ml of benzene:ethanol (9:1). The 
combined extracts were concentrated as described above and chromato-
graphed on silica gel in benzene:ethylacetate (9:1) with appropriate 
TABLE III 
EVIDENCE FOR THE RADIOCHEMICAL PURITY OF TESTOSTERONE 
AND RELATED STEROID DERIVATIVES 1 
Total dpm dpm Recovered 
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Percent Steroid as Steroid Chroma to graphed Derivative Derivatized 
[7-3H] 5S-Androstanediol 4,501 4,075 96,9 
[7- 3H] 3a-Androstanediol 15,361 15,045 97,9 
[7- 3H] 3S-Androstanediol 12,209 11,651 95,4 
[7- 3H] 5a-Androstanedione 694 684 98,5 
[4-14C] 5a-Androstanedione 2,426 2,319 95.6 
[ 4-14C] Androsterone 2,185 2,091 95.7 
[7- 3H] Androstenedione 1,540 1,465 95.2 
[4-14C] Androstenedione 16,927 16,640 98,3 
[ 4-14C] Dihydrotestosterone 15,167 14,469 95,4 
[4-14C] Estradiol 16,928 16,115 95,2 
[4-14C] Estrone 12,922 12,521 96,9 
[4-14C] Testosterone 16,682 16,165 96,9 
IAn derivatives are acetates except androstanedione and androstene-
dione which are methoxamines. 
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acetate standards chromatographed in separate lanes. Ten milligram 
quantities of 58- and 3S-androstanediol acetate standards, not commer-
cially available, were synthesized as above. The absorbent was scraped 
and eluted with benzene:ethanol (9:1) into a scintillation vial. The 
solvent was air dried and 12 ml scintillation fluid added to determine 
the amount of radioactivity present, For 5 of the 10 isolated steroids a 
tritium labeled internal standard was used to correct for recovery during 
acetate formation as shown: in Table IV. The rate of recovery during 
acetate formatiqn for the remaining steroids was not determined. 
Androstenedione and 5a.-androstanedione were derivatized using 
methoxylamine hydrochloride (Horning, et ~., 1968). An unknown sample 
or radioactive plus nonradioactive standard was placed in a tube and 
evaporated as above. Following the.addition of 0.5 ml of 16% methoxyla-
mine hydrochloride in pyridine, the mixture was heated at 60 C for 3 hr. 
The reaction was stopped by the addition of 2 ml of water, and the 
methoxime derivative extracted three times with 5 ml benzene:ethanol 
(9:1). The combined extracts were evaporated to approximately 5 ml and 
washed with 1 N hydrochloric acid, with distilled water, with 1% sodium 
bicarbonate solution, and finally with distilled water. The organic 
solution was dried and concentrated as above and chromatographed on 
silica gel in benzen.e:acetone (4:1) with an androstenedione methoxime or 
5a.-androstanedione methoxime standard (prepared in our laboratory by the 
above procedure) in separate lanes. Since the two isomers formed during 
the aboye reaction conditions were net separated in this chromatographic 
system, the methoxime derivatives migrate as a single spot. The silica 
gel was scraped, eluted, dried and counted as above. The purity was de-
termined by scraping the entire lane and expressing the purity of an 
Steroid Internal 
\ Standard 
E2 
El 
And 
T 
T 
DHT 
El 
E2 
DHT 
T 
TABLE IV 
EVIDENCE FOR THE RADIOCHEMICAL PURITY OF TESTOSTERONE AND RELATED 
STEROID DERIVATIVES BY USING AN INTERNAL STANDARD 
Total dpm Total dpm dpm 
Prior to Chroma togr aphed Recovered % % 
Acetylation Excluding as Derivatized Recovery Internal Std. Derivative 
50,414 41,400 39,827 96.2 
20,791 --· 16,487 -- 79.3 
30,922 23,024 22,264 96.7 
3,511 -- 2,532 -- 72.4 
8, 713 6,323 6,140 97.1 
7,807 -- 5,505 -- 70.5 
10,411 8,427 8,199 97.3 
14,396 -- 11 '341 -- 78.8 
39 '728 30,380 29,651 97.6 
3,511 -- 2,619 -- 74.6 
Calculated dpm 
Steroid Prior to 
Acetylation 
50,233 
30,752 
8,709 
10,405 
39 '74 7 
tn 
0 
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isolated compound as the percentage of dpm steroid derivative divided by 
the total dpm in the lane. Tables III and IV show evidence of the radio-
chemical purity of the acetate and methoxime derivatives. 
Quench Correction and Calcl,llations .to 
Arrive at dpm of ~ Isolated Steroid. 
The counting efficiency of each sample was determined by using an 
Automatic External Standard (226Ra) of a Packard Tri-Carb Liquid Scintil-
lation Spectrometer. Model 3220. 
A rectangular coordinate system was used to construct quench 
correction curves from a one-to-one correspondence between sets of points 
in a plane. Percent of counting efficiency was designated as points on 
the ordinate (y-axis) and counts per minute in the Automatic External 
Standard was designated as points on the abscissa (x-axis). 
3 For the pr~sent study, quench correction curves for [ H] and for 
[14c] were constructed using [3H] toluene and [14c] toluene as sources of 
radioactivity. Nitromethane was used as a quenching agent, and the 
measurements were made with double label settings on the liquid scintil-
lation spectrometer in a toluene based scintillation fluid. 
The following materials were added to 30 scintillation vials: 0.05 
ml [3H] toluene to 14 vials, 0.05 ml [14c] toluene .to another 14 vials, 
nitromethane in graduated amounts (0,005, 0.01, 0.02, 0,03, 0.04 and 0,05 
ml) to duplicate vials (12 vials each for [3H] toluene and [14c] 
toluene), and 12 ml toluene scintillation fluid to all vials. 
Thus two vials contained only toluene scintillation fluid to provide 
background measurements, four vials contained no quenching agent to pro-
vide radioactivity measurement of.the [3H] toluene (2 vials) and [14c] 
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toluene (2 vials) used as standards and 24 vials contained [3H] toluene 
(12 vials) or [14c] toluene (12 vials) plus graduated amounts of quench-
ing agent. Each vial was counted three times for ten minutes each. 
The density of toluene equals 0.8669 g/ml. The radioactivity of the 
tritium standard equalled (2.28 x 106 dpm/g times 0.794 decay correction 
factor) 1.81032 x 106 dpm/g. The 0.05 ml used in each vial represents 
(1.81032 x 106 dpm/g times 0.043345 g/0.05 ml) 78,468 dpm/0.05 ml of 
tritiated toluene. The radioactivity of the [14c] stanqard equalled 
4.94 x 105 dpm/g. The 0.05 ml used in each scintillation vial represents 
5 . 14 (4.94 x 10 dpm/g times 0.043345 g/0.05 ml) 21,412 dpm/0.05 ml of [ C] 
toluene. 
To determine the efficiency of .. the comting apparatus and the dpm of 
3H and 14c of an isolated steroid the following formulas were used: 
3H efficiency in 3H channel = cpm 
3H in 3H channel 
3 dpm H expected 
14c ff" · · e 1c1ency 1n 14 C channel = cpm 
14c in 14 C channel 
dpm 14c expected 
14c dpm isolated steroid = cpm in 
14c channel 
14c efficiency in 14c channel 
3 . . 
H dpm isolated steroid = 
net cpm in 3H ·c.hann~l :.' .L4C dpm x 14c efficiency in 3H channel 
3H ff" . . 3H h 1 e 1c1ency 1n c anne 
Experimental Design 
The present study was designed to compare the uptake, retention and 
metabolism of [3H] testosterone in normal, castrate and testosterone 
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treated rats. The rationale for this study is based on the finding that 
testosterone treated rats (subdermal testosterone-filled Silastic cap-
sule) are azoospermia and have suppressed pituitary LH and FSH secretion 
even though plasma testosterone remains within the normal range, The ob-
servation that testosterone is not elevated in rats experiencing a re-
duction in circulating LH and FSH titers cannot be explained on the basis 
of current concepts of how testosterone exerts its negative feedback on 
the hypothalamo-hypophyseal axis. To investigate this problem, [3H] tes-
tosterone was infused under steady state conditions and some of its 
tritiated metabolites isolated from various tissues, 
Experiment != Determination of Testosterone 
Release Rate and the Influence of Different 
Circulating Androgen Titers ~the Testis and 
Seminal Vesicle Weights 
The objectives of this experiment were to: (1) determine the amount 
2 
of testosterone released from subdermal Silastic capsules (200 mm ) for 
comparison with previously determined release rates and (2) to determine 
the influence testosterone treatment has on testis and seminal vesicle 
weights, The results were expressed as mg wet and dry testis and seminal 
vesicle weights ± standard error and as ~g testosterone released per day 
± standard error. The results were analyzed by a one-way analysis of 
variance (AOV) (Snedecor and Cochran, 1967), When the AOV revealed sig-
nificant variation, the differences between treatment means were assessed 
by Duncan's New Multiple Range Test (Steel and Torrie, 1960). 
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Experiment ~: Determination of the Time Required 
to Establish Steady-State Conditions for Plasma 
Testosterone 
This experiment was performed to determine the amount of time re-
quired for [3H] testosterone in plasma to be in an isotopic steady state. 
This was accomplished by infusing [1,2,6,7-3H] or [7- 3H] testosterone 
into four or five male rats from each treatment group (normal, castrate, 
and testosterone treated for 3 or 4 hr. Approximately 10 ml of blood was 
obtained from each animal and centrifuged, The plasma was.extracted, and 
testosterone isolated. The rate of testosterone infusion (dpm/100 g body 
weight/hr) was divided by the plasma testosterone concentration (dpm/ml) 
to give a radiotestosterone clearance rate (RCR). A mean RCR ±standard 
error for each treatment group and time period was obtained, Differences 
between treatment groups and times were determined as in Experiment 1. 
Experiment ~: Differential Metabolism of [3H] 
and [14c] Testosterone Following Constant 
Infusion for 3 Hours 
The purpose of this experiment was to determine whether tritiated 
forms of testosterone ([1,2,6,7- 3H] and [7- 3H]) were metabolized differ-
ently than the carbon 14 (4-14c) isotope of testosterone. This experi-
ment was performed by infusing radioactive testosterone at two different 
ratios of [3H] to [14c] into the three treatment groups. The first ex-
periment was carried out by infusing [1,2,6,7- 3H] and [4- 14c] testosterone 
at a ratio of 18 to 1 into two animals per group for 3 hr. The second 
experiment was performed by using a ratio of 8 to 1 of [7- 3H] to [4-14c] 
testosterone infused into four animals per group for 3 hr. Testosterone 
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was isolated from the pituitary gland hypothalamus, cerebral cortex, 
prostate, testis, liver and plasma and counted for double label. The 
results were expressed as the mean tissue:infusion ratio± standard 
error. Th . · · d f' d h · f 3H 14c · h · 1s rat1o 1s e 1ne as t e rat1o o : 1n t e t1ssue 
divided by the ratio of 3H: 14c infused, Failure to detect a difference 
in the metabolism of the two isotopic forms of testosterone should result 
in a ratio that is approximately equal to 1.00. The results were 
analyzed as in Experiment 1. 
Experiment != Distribution of [ 3H] Testosterone 
and Some of its Tritiated Metabolites Following 
3 Infusion of [1,2,6,7- H] Testosterone in Normal, 
Castrate and Testosterone Treated Male Rats 
This experiment was performed to determine whether or not castration 
or testosterone treatment modified the uptake and/or metabolism of tes-
tosterone in the pituitary gland, hypothalamus, cerebral cortex, prostate, 
testis, liver and plasma of 3 animals from each group. Testosterone and 
9 of its metabolites ~ere isolated from each tissue following constant 
3 infusion of [1,2,6,7- H] testosterone for 3 hr. The results were ex-
pressed in terms of dpm per 100 mg tissue or as the mean relative per-
centage of the isolated compounds (calculated by dividing dpm/100 mg of a 
compound by the total radioactivity isolated in that tissue). Treatment 
differences were analyzed as in Experiment 1. 
Experiment ~: Distribution of [ 3H] testosterone 
and Some of its Tritiated Metabolites Following 
Constant Infusion of [7- 3H] Testosterone in 
NormalJ Castrate and Testosterone Treated Male 
Rats 
This experiment was performed exactly as Experiment 4 except that 
four animals per treatment group were infused with [7- 3H] testosterone. 
The results were expressed and analyzed as in Experiment 4, 
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CHAPTER IV 
RESULTS 
The purpose of the present study was to determine the relationship 
of endogenous testosterone levels on the capacity of androgen dependent 
tissue to concentrate. retain and metabolize [3H] testosterone under 
equilibrium or steady state conditions. To accomplish this objective 
preliminary experiments were performed to establish the criteria needed 
to administer testosterone and to validate the constant infusion pro-
cedure used to assess the uptake, retention and metabolism of [3H] 
testosterone. 
Experiment 1: Determination of Testosterone 
Release Rate and the Influence of Different 
Circulating Androgen Titers on the Testis 
and Seminal Vesicle Weights 
Testosterone was released from subdermal Silastic capsules at a rate 
of 120.96 ~g/day ± 5,78 (Table V). Rats receiving this 200 mm2 
testosterone-filled Silastic capsule for four weeks experienced a signif-
icant (p < 0,005) reduction in testicular wet and dry weight, but the wet 
and dry weight of the seminal vesicles remained (p > 0.05) near normal, 
As expected, castration significantly (p < 0.005) decreased the seminal 
vesicle wet and dry weights. 
57 
Treatment 
Normal 
Castrate 
Testosterone 
Treated 
TABLE V 
TESTIS AND SEMINAL VESICLE WET AND DRY WEIGHTS OF 
NORMAL, CASTRATE AND TESTOSTERONE TREATED 
MALE RATS AND2THE MEAN RELEASE RATE OF 
THE 200 mm SILASTIC 1 CAPSULES 
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Testes Weight Seminal Vesicle Jlg Testosterone 
n (mg) Weight* (mg) 
Wet Dry Wet Dry Released/Day 
12 3304,922 447.64 321.67 70.57 
±81. 87 ±12.13 ±19.40 ±4.24 
12 79.06 16.78 
±3.94 ±0.86 
20 2344.52 342.75 384.80 84,50 120,96 
±64.99 ±9.18 ±15,86 ±4,08 ±5.78 
1Polydimethylsi1oxane, 
2Each value is the mean ± standard error of the indicated number of 
animals, 
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Experiment 2: Determination of the Time 
Required to Establish Steady State 
Conditions for Plasma 
Tes.tosterone 
The results of this experiment showed that the radiotestosterone 
clearance rate (RCR) remained relatively constant (p > 0.05) between 3 or 
4 hr after infusing [1,2,6,7- 3H] testosterone to either normal, castrate 
or testosterone treated rats (Table VI). The RCR was slightly lower in 
testosterone treated rats than in normal or castrate animals, but this 
difference was not significant (p > 0.05). 
The RCR of rats infused with [7- 3H] testosterone was slightly lower 
than that obtained with [1,2,6,7- 3H] testosterone but was not signifi-
cantly (p > 0, 05) different, Thus, the concentration of radiolabeled 
testosterone in plasma was in a steady state 3 hr after the onset of 
constant infusion. As a result, 3 hr infusion intervals were used in 
all subsequent experiments, 
Experiment 3: Differential Metabolism of [3H] 
and [14c] Testosterone Following Constant 
Infusion for 3 Hours 
Radiolabeled testosterone ([7- 3H] or [1,2,6,7- 3H] and [4- 14c]) was 
infused for 3 hr at two different ratios to establish that the ratio of 
3H: 14c in the tissues investigated remained relatively constant (Table 
VII), The tissue: infusicm .ratio should be equal to approximately L 00 in 
3 14 
order to show that [ H] and [ C] testosterone were not differentially 
metabolized. 
The results of this exp.er.iment. showed that the tissue: infusion ratio 
TABLE VI 
RADIOTESTOSTERONE CLEARANCE RATE 1 OF [3H] TESTOSTERONE 
OF ADULT MALE RATS AT THE END OF 3 OR 4 HOUR 
INFUSIONS WITH [1,2,6.7-3H] OR [7-3H] 
TESTOSTERONE 
Infusion Treatment 
60 
Number of Infused Isotope Time Animals Normal Castrate Testosterone (hr) 
3 5 
3 [1,2,6,7- H] 
4 4 
3 4 
4 4 
665 2 
±38 
660 
±65 
587 
±33 
587 
±24 
694 
±40 
672 
±27 
607 
±30 
582 
±27 
Treated 
566 
±39 
576 
±76 
568 
±32 
563 
±37 
1Radiotestosterone clearance rate is defined as the ratio of the 
rate of infusion of labeled testosterone (dpm/100 g body weight/hr and 
the plasma testosterone concentration (dpm/ml). 
2Each value (ml/hr/100 g body weight) is expressed as the mean ± 
standard error of the indicated number of animals. 
TABLE VII 
THE TISSUE:INFUSION RATI0 1 FOLLOWING INFUSION OF [1,2,6,7- 3H] 
OR [7-3H] AND [4-14c] TESTOSTERONE FOR 3 HOURS IN 
VARIOUS TISSUES OF NORMAL, CASTRATE AND 
TESTOSTERONE TREATED MALE RATS 
Treatment Tissues Prostate Plasma Pituitary Hypothalamus Cortex Testis 
Normal 1.112 0.97 0.82 1. 07 1.01 1.00 
±0.10 ±0.06 ±0.16 ±0.04 ±0.03 ±0.03 
Castrate 1.14 0.96 1.16 1.08 0.85 --
±0.13 ±0.01 ±0.19 ±0.17 ±0.06 
Testosterone 0.90 0.98 1.04 0.98 1.11 0.80 
Treated ±0.13 ±0.05 ±0.07 ±0.02 ±0.20 ±0.12 
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Liver 
1.23 
±0.33 
1.77 
±0,33 
1.08 
±0.19 
1The tissue:infusion ratio is defined as the isolated testosterone 
ratio (3H dpm;l4c dpm) and the infused testosterone ratio (3H dpm;l4c 
dpm) in the various tissues. 
2Each value is the mean tissue:infusion ratio± standard error of 
six determinations (two using [1,2,6,7-3H] testosterone and four using 
[7-3H] testosterone, 
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was approximately equal to 1.00 in all of the tissues investigated. In 
addition, no significant differences (p > 0.05) in the tissue:infusion 
ratio were apparent for any of the tissues exposed to different endogenous 
testosterone levels. Furthermore, there was no measurable difference in 
this ratio when [1,2,6,7- 3H] or [7- 3H] testosterone was infused with 
14 [ C] testosterone. Since the results failed to reveal any differences 
in the metabolism of the two isotopic forms of testosterone, it was as-
sumed that both forms of testosterone were metabolized in the same manner 
as endogenous testosterone. 
Experiment 4: Distribution of [3H] Testosterone 
and Some of its Tritiated Metabolites Following 
Infusion of [1,2,6,7- 3H] Testosterone for 3 
Hoursin Normal, Castrate and Testosterone 
Treated Male Rats 
Pituitary Gland 
Estraction of [ 3H] testosterone and other tritiated metabolites es-
tablished that 35-40% of the total radioactivity isolated in the pituitary 
gland of all animals was present as testosterone. In all the animals 
dihydrotestosterone accounted for 20-30% and the two estrogens 10-20% of 
the isolated radioactivity (Figure 3). The concentration of [3H] testes-
terone (dpm/100 mg) retained in the pituitary gland of testosterone 
treated rats was significantly (p < 0.05) higher than that found in the 
pituitary gland of either normal or castrate animals (Figure 4 and Table 
VIII), The pituitary gland of castrate animals also was capable of re-
taining 10% of the isolated radioactivity as androstenedione. 
Figure 3. Relative Percentage of Isolated Compounds in Cerebral Cortex, 
Hypothalamus and Pituitary of Normal :::;:, Castrate ~, 
and Testosterone Treated ~ Male Rats Following 3 Hr 
Infusion of [1,2,6,7-3H] Testosterone 
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Figure 4, Radioactive Concentration of Testosterone (dpm x 1031100 mg 
Tissue) in Various Tissues of Normal, Castrate and 
Testosterone Treated Male Rats Following 3 Hr Infusion of 
[1,2,6,7-3H] Testosterone 
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TABLE VIII 
DISTRIBUTION OF TESTOSTERONE AND SOME OF ITS TRITIATED METABOLITES FOLLOWING INFUSION OF [1,2,6,7- 3H] 
TESTOSTERONE FOR 3 HOURS INTO NORMAL (N), CASTRATE (C) AND TESTOSTERONE TREATED (TT) MALE RATS 
Tissue Treatment 
Isolated Steroids 
Testa 5a-DHT Andro 3a-diol 3B-diol 5a-stane 56-diol b.4-stene El E2 
N 10071 1 7711 131 1135 215 1694 598 -- 5441 2287 
±497 ±2087 ±98 ±380 ±14 ±1047 ±115 ±910 ±1816 
Pituitary c 9873 5320 709 1602 366 1205 619 3169 1581 5695 
±470 ±853 ±513 ±242 ±98 ±157 ±103 ±1675 ±1491 ±1341 
TT 16632 6771 803 2547 256 4965 754 3270 5334 6681 
±450 ±1591 ±448 ±100 ±40 ±2735 ±80 ±2211 ±3483 ±1087 
-------------
-------------
-------------
-------------
--
N 2734 1221 204 228 144 231 137 280 407 695 
±148 ±320 ±52 ±90 ±87 ±22 ±28 ±147 ±204 ±266 
Hypothalamus c 2908 1701 447 524 135 501 194 311 265 1249 
±207 ±135 ±35 ±83 ±32 ±235 ±27 ±176 ±131 ±446 
TT 2884 846 176 411 96 241 125 291 675 384 
±147 ±236 ±31 ±47 ±4 ±136 ±5 ±190 ±144 ±152 
-------------
-------------
-------------
-------------
--
N 2126 569 128 194 40 157 81 219 132 342 
±111 ±106 ±16 ±66 ±14 ±0 ±16 ±82 ±13 ±58 
C. Cortex c 2319 1038 544 329 78 220 140 539 156 402 
±71 ±345 ±166 ±74 ±5 ±94 ±14 ±34 ±101 ±83 
TT 1685 541 157 265 59 35 55 237 420 279 
±35 ±28 ±38 ±36 ±3 ±15 ±13 ±51 ±71 ±12 
-------------
-------------
-------------
-------------
--
0'\ 
-...] 
TABLE VIII (Continued) 
Tissue Treatment Isolated Steroid Testa Sa. -DHT Andro 3a.-diol 3f3-diol Sa.-stane 5f3-diol f1 4-stene El E2 
N 975 8942 550 405 25 389 58 184 101 111 
±123 ±1513 ±181 ±232 ±15 ±lOS ±8 ±150 ±65 ±78 
Prostate c 4956 28900 1250 980 603 1108 411 1386 1247 3607 
±554 ±5730 ±291 ±8 ±227 ±559 ±45 ±598 ±878 ±535 
TT 710 4695 254 587 165 140 53 170 191 139 
±216 ±107 ±30 ±50 ±97 ±52 ±6 ±29 ±59 ±70 
------------------------------------------------------N 1615 139 80 234 62 45 66 193 182 124 
Testis ±48 ±53 ±10 ±74 ±23 ±25 ±12 ±100 ±45 ±121 
TT 2834 264 43 400 102 5 55 240 249 141 
±442 ±;35 ±8 ±102 ±22 ±5 ±55 ±97 ±111 ±68 
------------------------------------------------------
N 318 460 1417 416 1179 48 1315 248 141 119 
±20 ±143 ±721 ±72 ±431 ±23 ±381 ±77 ±23 ±37 
Liver c 232 1198 25229 8228 40355 164 1610 240 82 186 
±9 ±337 ±13095 ±3228 ±2374 ±74 ±110 ±33 ±80 ±79 
TT 201 253 1228 645 1783 49 1059 29 132 163 
±35 ±77 ±467 ±45 ±86 ±35 ±296 ±29 ±68 ±16 
------------------------------------------------------
N 996 26 20 106 35 13 45 29 26 18 
±88 ±14 ±4 ±7 ±15 ±3 ±13 ±15 ±1 ±7 
Plasma c 1007 67 93 136 53 8 124 95 25 15 
±71 ±1 ±14 ±0 ±3 ±1 ±19 ±16 ±14 ±7 
TT 1201 62 35 203 91 4 74 60 12 27 
±212 ±13 ±6 ±8 ±19 ±4 ±31 ±12 ±9 ±5 
1Each value is the mean dpm/100 mg ± standard error of 3 animals. Q'\ 00 
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Hypothalamus 
The data demonstrated that the hypothalamus of all the animals re-
tained lS-20% of the isolated radioactivity as [3H] dihydrotestosterone 
and lS-20% in the form of the two estrogens (Figure 3). However, the 
majority (3S-4S%) of radioactivity present in the hypothalamus of all 
animals was retained as [3H] testosterone (Figure 3). Castration slightly 
increased (p > O.OS) the retention of tritiated Sa-reduced metabolites 
and tritiated estradiol above that found in the hypothalamus of normal or 
testosterone treated rats (Table VIII). The total amount of the isolated 
radioactivity (dpm/100 mg) retained in the hypothalamus of all animals 
was much lower than that found in the pituitary (Table VIII). 
Cerebral Cortex 
In all animals this tissue retained 40-SO% of the isolated radio-
activity as [3H] testosterone, but also retained 2S-3S% as Sa-reduced 
androgen metabolites and 10-lS% as the two estrogens (Figure 3). Castra-
tion caused a significant increase in the retention of testosterone 
(p < O.OS), androsterone (p < O.OS), SS-androstane-3a, 17S-diol 
(p < 0.02S) and androstenedione (p < 0.02S) above that found in the 
cortex of normal or testosterone treated animals (Table VIII). The 
amount (dpm/100 mg and relative distribution (%) of isolated radioactivity 
was comparable to that found in the hypothalamus (Table VIII and Figure 
3). 
Prostate 
The majority (60-7S%) of the radioactivity in the prostate of all 
animals was in the form of [3H] dihydrostestosterone and 10% was present 
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as [3H] testosterone (Figure 5). The concentration (dpm/100 mg) of [3H] 
testosterone, [3H] 58-androstane-3a, 178-diol and [3H] estradiol were all 
significantly higher (p < 0.05) in castrate animals than both the normal 
and implanted animals. Castration also greatly increased the radio-
activity retained as [3H] dihydrostestosterone (p < 0.025) and [3H] 
androsterone (p < 0,05) above that found in prostatic tissue from 
testosterone treated but not normal animals (Table VIII). 
Testis 
The testis of both normal and testosterone treated animals showed 
the capacity to retain infused testosterone as [3H] dihydrostestosterone 
(5-7%) and 5a-androstane-3a, 178-diol (9%), but 60-65% of the radio-
activity isolated was retained as [3H] testosterone (Figure 5). More-
over, radioactive testosterone (dpm/100 mg) in the testis of testosterone 
treated animals was almost twice (p < 0.05) that found in normal animals 
(Table VIII). Testosterone treatmept did not affect the retention of 
radioactivity as estrogens (Table VIII). 
Liver 
Hepatic tissue from normal, castrate and testosterone treated rats 
freely metabolized infused testosterone. The majority of radioactivity 
isolated from hepatic tissue of all animals (Figure 5) was in the form of 
[3H] androsterone (25%), [3H] 5a-androstane-38, 178-diol (30-50%) and 
[3H] 58-androstane-3a, 178-diol (15-20%). Castration significantly in-
creased (p < 0,005) the amount of'radioactivity (dpm/100 mg) isolated in 
the form of [3H] androsterone, [3H] 5a-androstane-3a, 178-diol and [3H] 
5a-androstane-3a, 178-diol (Table VIII). Testosterone treatment did not 
Figure 5. Relative Percentage of Isolated Compounds in Prostate, Testis 
and Liver of Normal 1::~:~, Castrate ~, and Testosterone 
Treated ~ Male Rats Following 3 Hr Infusion of 
[1,2,6,7~Testosterone 
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significantly affect (p > 0.05) the hepatic metabolism of infused testos-
terone (Table VIII and Figure 5). 
Plasma 
The majority of radioactivity found in plasma of all animals (Figure 
6) was isolated as [3H] testosterone (65-75%). Any other single radio-
active metabolite present in plasma from all animals accounted for less 
than 5% of the total isolated, except for [3H] 5a-androstane-3a, 17S-
diol (8-11%) and [3H] 5S-androstane-3a-17S-diol (5-7%), 
Experiment 5: Distribution of [3H] Testosterone 
and Some of its Tritiated Metabolites Following 
Infusion of [7- 3H] Testosterone in Normal, 
Castrate and Testosterone Treated 
Male Rats 
Pituitary Gland 
After constant infusion of [7- 3H] testosterone, pituitary tissue 
demonstrated the capacity to retain radioactivity as [3H] dihydrotestos-
terone (5-15%) and the two estrogens (10-20%). The majority of infused 
[7- 3H] testosterone retained as [3H] testosterone (40~60%) was higher 
than [3H] testosterone (35-40%) retained by the pituitary gland after in-
fusion of [1,2,6,7] testosterone (Figures 3 and 7). As in Experiment 4, 
[3H] testosterone (dpm/100 mg) retained in the pituitary gland of testos-
terone treated animals following [7- 3H] testosterone infusion was signif-
icantly higher (p < 0.05) than that found in the pituitary of either 
castrate or normal animals (Figure 8 and Table IX). 
Figure 6. Relative Percentage of Isolated Compounds in Plasma of Normal 
~:;:: , Castrate ~ and Testosterone Treated ~ Male 
Rats Following 3 Hr Infusion of [1,2,6,7-3H] Testosterone 
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Figure 7, Relative Percentage of Isolated Compounds in Cerebral Cortex, 
Hypothalamus and Pituitary of Normal ;;::·, Castrate ~ 
and Testosterone Treated ~ Male Rats Following 3 Hr 
Infusion of [7-3H] Testosterone 
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Figure 8. Radioactive Concentration of Testosterone (dpm x 10 31100 mg 
Tissue) in Various Tssiues of Normal, Castrate and 
Testosterone Treated Male Rats Following 3 Hr Infusion of 
[7-3H] Testosterone 
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TABLE IX 
DISTRIBUTION OF TESTOSTERONE AND SOME OF ITS TRITIATED METABOLITES FOLLOWING INFUSION OF [7- 3H] TESTOSTERONE 
FOR 3 HOUR INTO NORMAL (N), CASTRATE (C) AND TESTOSTERONE TREATED (TT) MALE RATS 
Tissue Treatment Isolated Steroids Testo 5a.-DHT Andro 3a.-diol 3S-diol 5a.-stane 5S-diol 114-stene El E2 
N . 15042 1 2197 733 2635 270 2325 722 2028 1440 1627 
±2824 ±759 ±313 ±386 ±36 ±1162 ±118 ±400 ±695 ±323 
Pituitary c 6396 3112 409 979 264 1073 684 1509 2421 1129 
±1040 ±1060 ±409 ±306 ±76 ±382 ±212 ±490 ±937 ±491 
TT 30100 1621 -- 2070 756 2398 710 2041 2176 2231 
±7153 ±950 ±509 ±320 ±464 ±60 ±87 ±819 ±809 
------------------------------------------------------
N 2313 702 67 516 41 166 160 274 264 188 
±140 ±55 ±38 ±186 ±10 ±60 ±80 ±10 ±34 ±29 
Hypothalamus c 1868 880 419 136 44 300 89 219 68 72 
±39 ±135 ±320 ±6 ±3 ±45 ±31 ±71 ±42 ±39 
TT 1789 631 46 194 50 106 59 198 -- 170 
±259 ±226 ±17 ±36 ±8 ±41 ±11 ±26 ±102 
------------------------------------------------------
N 1634 601 338 319 57 79 58 172 82 63 
±148 ±181 ±181 ±97 ±11 ±15 ±13 ±17 ±15 ±16 
C. Cortex c 2182 599 569 323 62 210 71 116 175 85 
±482 ±339 ±283 ±116 ±13 ±90 ±13 ±22 ±89 ±27 
TT 3215 558 20 281 72 172 80 175 80 108 
±1292 ±150 ±13 ±27 ±14 ±51 ±19 ±41 ±61 ±36 
------------------------------------------------------
00 
0 
TABLE IX (Continued) 
Tissue Treatment Isolated Steroids Testo 5a-DllT Andro 3a-diol 313-diol 5a-stane 5S-diol Li.4-stene El E2 
N 1222 8093 342 1117 104 437 154 128 123 294 
±23 ±466 ±78 ±162 ±11 ±105 ±48 ±19 ±43 ±268 
Prostate c 4817 11757 1499 775 71 257 192 600 491 337 
±1693 ±1136 ±638 ±173 ±5 ±112 ±13 ±131 ±220 ±223 
TT 628 5121 255 494 98 352 60 259 32 43 
±172 ±1279 ±39 ±40 ±17 ±62 ±6 ±70 ±6 ±15 
------------------------------------------------------
N 1324 85 17 308 92 92 83 93 27 40 
Testis ±83 ±11 ±17 ±62 ±13 ±54 ±18 ±7 ±22 ±17 
TT 2438 58 92 324 99 22 67 74 90 52 
±571 ±15 ±51 ±22 ±10 ±6 ±24 ±16 ±9 ±20 
------------------------------------------------------
N 244 188 106 203 267 72 759 81 42 41 
±57 ±68 ±58 ±38 ±62 ±22 ±110 ±18 ±28 ±8 
Liver c 345 693 1557 1447 10176 45 913 75 67 80 
±199 ±376 ±532 ±426 ±4291 ±24 ±169 ±36 ±16 ±10 
TT 144 69 94 480 922 47 492 46 45 58 
±87 ±59 ±24 ±131 ±239 ±22 ±94 ±18 ±17 ±25 
------------------------------------------------------
N 853 26 25 109 39 4 154 83 6 5 
±40 ±6 ±9 ±30 ±5 ±3 ±31 ±22 ±2 ±2 
Plasma c 731 13 32 75 34 6 55 40 3 5 
±32 ±5 ±12 ±4 ±2 ±3 ±15 ±12 ±1 ±1 
TT 816 18 60 164 74 5 65 67 9 7 
+39 +4 +40 +24 +12 +3 +4 +5 +5 +4 
1Each value is the mean dpm/100 mg ± standard error of 4 animals. 00 ~ 
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Hypothalamus 
After infusion of [7- 3H] testosterone hypothalamic tissue demon-
strated the capacity to retain radioactivity in the form of both dihydro-
testosterone (15-25%) and the two estrogens (2-6%) (Figure 7), The 
radioactivity isolated as the two estrogens (2-6%) in the hypothalamus of 
all animals after infusion of [7- 3H] testosterone was much less than in 
the hypothalamus (10-20%) after [1,2,6,7- 3H] testosterone infusion 
(Figures 3 and 7). The majority (45-55%) of the radioactivity retained 
in the hypothalamus of all animals was in the form of [3H] testosterone, 
The total quantity (dpm/100 mg) of isolated radioactivity retained in the 
hypothalamus of all animals was much lower than the total amount retained 
by the pituitary (Table IX). 
Cerebral Cortex 
This supposedly androgen insensitive tissue in all animals demon-
strated (Figure 7) the capacity to retain infused [7- 3H] testosterone in 
3 the form of [ H] Sa-reduced products (30%) and the two estrogens (10%). 
The majority (50-60%) of radioactivity isolated in the cortex of all ani-
mals was retained as testosterone which agrees with the results of 
Experiment 4. A comparison of the uptake and metabolism of [7- 3H] tes-
3 tosterone (Table IX) and [1,2,6,7- H] testosterone (Table VIII) shows 
that after either radiolabeled testosterone was infused the cerebral 
cortex from all animals demonstrated an increased retention due to cas-
tration but only after [1,2,6,7-3H] testosterone was this increase sig-
nificant (p < 0.05) for a number of compounds isolated. The total amount 
of radioactivity (dpm/100 mg) isolated in the cortex of all animals was 
much less than that found in the pituitary gland but slightly higher than 
83 
that present in the hypothalamus following [7- 3H] testosterone infusion 
(Table IX). 
Prostate 
In agreement with the results of Experiment 4, the majority (57-68%) 
of the radioactivity isolated in prostatic tissue from all animals was in 
the form of [3H] dihydrotestosterone and 10-20% was present as [3H] tes-
tosterone (Figure 9). The quantity (dpm/100 mg) of radioactivity iso-
lated from the prostate as [3H] testosterone was significantly higher 
(p < 0,01) in castrate animals than both the normal and testosterone 
treated animals. Castration also increased the retention of [3H] 
dihydrotestosterone (p < 0.01), [3H] androstenedione (p < 0.01) and [3H] 
estrone (p < 0.05) in the prostate above testosterone treated but not 
normal animals (Table IX). Testosterone treatment did not significantly 
alter the retention or metabolism in the prostate following [7- 3H] 
testosterone infusion. 
Testis 
The testis from both normal and testosterone treated rats demon-
strated the capacity to retain very little [3H] dihydrotestosterone (24%) 
but a greater amount was retained as 5a-androstane-3a, 176-diol (10-15%). 
However, the majority (60-70%) of the radioactivity isolated in this 
tissue was [3H] testosterone (Figure 9). The concentration of [3H] tes-
tosterone (dpm/100 mg) isolated from the testis of testosterone treated 
animals was almost twice that found in the testis of normal animals 
(Table IX). 
Figure 9o Relative Percentage of Isolated Compounds in Prostate, Testis 
and Liver of Normal :::::. , Castrate ~ and Testosterone 
Treated ~ Male Rats Following 3 Hr Infusion of [7-3H] 
Testosterone 
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Liver 
The majority of radioactivity isolated from the liver of all animals 
(Figure 9) was in the form of [ 3H] 5a-androstane-3S, 17S-diol (20-60%), 
[3H] 58-androstane-3a, 178-diol (10-40%), [3H] 5a-androstane-3a, 178-diol 
(10-20%) and [3H] androsterone (5-10%). Castration significantly 
(p < 0.025) increased the amount of radioactivity (dpm/100 mg) isolated 
from liver in the form of [3H] 5a-androstane-3a, 178-diol and [3H] 5a-
androstane-38, 178-diol above that of hepatic tissue from normal and tes-
tosterone treated animals (Table IX}. Testosterone treatment did not 
significantly (p ~ Q.05) affect the hepatic metabolism of infused testos-
terone. The total amount of radioactivity retained in the liver after 
[7- 3H] testosterone infusion was lower than after [1,2,6,7-3H] testos-
terone infusion (Tables VIII and IX). 
Plasma 
The majority of radioactivity found in plasma of all animals (Figure 
10) was isolated as [3H] testosterone (64-73%). Any other single radio-
active metabolite investigated in plasma of all animals accounted for less 
than 5% of the total isolated, except for [3H] 5a-androstane-3a, 178-diol 
(7-12%) and [3H] 5S-androstane-3a, 178-diol (5-12%). 
Figure 10. Relative Percentage of Isolated Compounds in Plasma of 
Normal ::::; , Castrate ~, and Testosterone Treated ~ Male Rats Following 3 Hr Infusion of [7-3H] 
Testosterone 
0 
CX) 
<( 
:e 
CJ) 
<( 
...J 
a.. 
C\1 
w 
·w 
IW 
"'I'Z 
<Jw 
..... 
CJ) 
...J 
0 
0 
I 
~ 
w 
IZ 
Cl <( 
IOt-
CJ) 
...J 
0 
0 
I 
c:n.. 
J'() 
...J 
""""""""'0 
0 
I 
r8 
0 
0::: 
0 
z 
<( 
88 
CHAPTER V 
DISCUSSION 
The regulatory effects of circulating testosterone on pituitary 
gonadotropin secretion has been studied extensively in recent years and 
resulted in the description of a "negative feedback loop'' (Davidson, 
1969). This feedback theory postulates that if circulating testosterone 
levels increase, plasma gonadotropin levels will decrease; but if plasma 
testosterone levels remain within the normal range, circulating gonado-
tropin levels will also be normal. However, using testosterone-filled 
Silastic capsules of appropriate wall thickness and surface area, differ-
ent laboratories have shown that normal plasma testosterone levels can be 
maintained but plasma concentrations of LH and FSH in rats (Berndtson, 
et ~., 1974), rabbits (Desjardins,~~., 1974) and men (Frick, 1973) 
fall far below normal, The failure to detect an elevation in plasma tes-
tosterone concentration coincides with the finding that the weight of the 
seminal vesicles and ventral prostate gland in testosterone treated ani-
mals are similar to those found in untreated animals despite a signifi-
cant reduction in testis size. 
The results obtained from this study (Experiment 1) confirm the ob-
servations of Berndtson, ~~· (1974) that testosterone-filled Silastic 
capsules caused testicular atrophy without affecting seminal vesicle 
weight in adult rats. Testosterone release rate found in the present 
study (121 llg/day) agrees closely with the value reported by Berndtson, 
89 
~ al. (1974) and was near that value of 138 ~g/day needed to cause in-
fertility in male rats (Reddy and Prasal, 1973). As expected, castrate 
animals with low levels of circulating testosterone (Verjans, et al., 
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1975) showed extreme atrophy of the seminal vesicles. The physiological 
significance of these findings is that plasma testosterone levels may not 
reflect the regulatory role this steroid proportedly plays in modulating 
pituitary gonadotropin secretion. 
The present investigation was designed to study two possible expla-
nations for the failure of the testosterone treated rats to exhibit the 
normal testosterone-gonadotropin relationship. One possibility is that 
testosterone from the Silastic capsules is metabolized to another hormonal 
steroid (Berndston, ~ al., 1974) which inhibits gonadotropin secretion 
or secondly, testosterone-filled Silastic capsules causes an increased 
uptake of androgens in the pituitary gland or brain. Prior to examining 
these possibilities, experiments were conducted to validate the continu-
ous infusion procedure used to assess the uptake, retention and metabolism 
3 
of [ H] testosterone. 
As the specific activity of an infused material increases in plasma, 
the amount of radioactivity removed from the circulation also increases 
since the total rate of removal of the compound is assumed to be constant. 
After a predetermined length of infusion, the rate of exit of the labeled 
compound will approximately equal its rate of entry into the circulation, 
and an isotopic steady state is established. The distribution of 
tritiated testosterone and its labeled metabolites during an isotopic 
steady state can be expected to approximately mimic the distribution of 
endogenous androgens (Gurpide, 1971). 
A radiotestosterone clearance rate (RCR) was used in the present 
study (Experiment 2) to determine that plasma radiolabeled testosterone 
was in a steady state three hours after infusing either [1,2,6,7- 3H] or 
3 [7- H] testosterone. It should be noted that a correction for any dif-
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ference in body weight has been included in the RCR. The RCR is related 
to the metabolic clearance rate (MCR) for testosterone but the calcula-
tions for RCR were performed on the assumption that testosterone is dis-
tributed in only one compartment. However, testosterone may be 
distributed in two or more compartments or pools with the "inner" pool in 
rapid equilibrium with plasma and an "outer" pool in much slower equilib-
rium (Tait and Horton, 1966). This outer pool may involve conjugation to 
gluronides or sulfates. In order to arrive at a value for the MCR of 
testosterone it would be necessary to obtain accurate measurements of 
both the inner and outer pools. This was impossible in the present 
experiment. Thus, the RCR is an approximation of the MCR for testoster-
one. The plasma concentration of radioactive testosterone was essentially 
the same for all groups indicating that all animals were in a steady 
state for radioactive testosterone. In addition, the RCR was not signif-
icantly different for any of the groups indicating that the different 
levels of exposure to testosterone experienced by these animals did not 
exceed their capacity to clear unconjugated radioactive testosterone. 
Assuming an 8% blood volume and an average RCR of 600 ml/hr/100 g 
body weight, a half-life of 30.seconds for unconjugated radioactive tes-
tosterone in plasma can be calculated. A similar half-life (50 seconds) 
can be calculated for estrone (MCR = 550 ml/hr) in the female rat from 
previously published data (DeHertogh, et al., 1970). Thus, this high 
clearance rate and short.half-life may account for the much lower plasma 
level of endogenous testosterone (1-10 ng/ml) than endogenous levels of 
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other steroids. 
Protein binding of testosterone in the plasma of man decreases MCR 
(Verneulen and Verdonch, 1969) and thus increases the half-life of this 
steroid. The finding that the RCR of testosterone treated animals was 
slightly but not significantly lower than castrate or normal animals 
suggests that testosterone filled Silastic capsules may increase the 
capacity of plasma proteins to bind testosterone, However, the plasma of 
rats does not contain a testosterone binding globulin as does the plasma 
of man (Corvol and Borden, 1973). This fact could explain why the rat 
exhibits a much higher clearance rate and shorter half-life of 
testosterone. 
The validity of any experiment using labeled steroids to investigate 
steroid metabolism depends on the assumption that the labeled and endoge-
nous material are metabolized in a similar manner. This assumption was 
verified in the present study by infusing two different ratios of [3H] 
14 testosterone:[ C] testosterone. A tissue:infusion ratio (TIR) of tritium 
to carbon-14 would ideally be equal to 1.00 if both isotopic forms of 
testosterone are metabolized in a similar manner, The results of Experi-
ment 3 demonstrate that the TIR of all tissues studied was approximately 
equal to 1.00 regardless of the treatment imposed on the animal. The 
variability in the TIR could be due to: (1) the inherent variability be-
tween animals used for an in vivo exPeriment; (2) the inability to monitor 
recovery via an internal standard; and (3) the necessity to infuse a 
small amount of radioactivity in an attempt to maintain the mass of tes-
tosterone within the normal range, thereby decreasing the sensitivity of 
the counting procedure. 
The hypothalamus, testis and cerebral cortex from all animals had 
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the lowest variability and a TIR closest to 1.00. This finding suggests 
that there is a limited testosterone metabolism in these tissues. The 
higher variability of the TIR noted in the prostate, pituitary gland and 
liver of all animals suggests that these tissues have a higher capacity 
to metabolize infused testosterone. As seen below, the capacity of the 
liver to metabolize infused testosterone is so high and [3H] testosterone 
isolated from liver so low that the determination of TIR approaches the 
limit of sensitivity of the counting procedures. Measurement of the 
total radioactivity rather than only testosterone concentration in the 
tissues would have been more advantageous because the use of total radio-
activity would be indicative of the true TIR and the higher radioactivity 
would increase the sensitivity of the counting procedures. However, the 
accepted procedure (DeHertough, ~ al., 1970) used to extract the total 
radioactivity from tissues and plasma (acetone extraction) did not 
repeatedly remove at least 80% of both organic and aqueous soluble 
tritium-labeled standards added to' the tissues. Therefore, the use of 
the radioactive testosterone isolated in the tissues had to be used in 
determining TIR. Since the TIR was close to 1.00, it was assumed that 
tritium-labeled testosterone and endogenous testosterone were metabolized 
in a similar manner. 
The results of Experiments 2 and 3 established that [3H] testosterone 
was in an isotopic steady state and was metabolized in a similar manner 
to endogenous testosterone. Therefore, it was decided to study the rela-
tionship of endogenous testosterone levels on the capacity of androgen 
dependent tissue to retain and metabolize tritiated testosterone under 
these steady state conditions. 3 [1,2,6,7- H] testosterone was chosen for 
use in Experiment 4 because it had the highest specific activity 
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available. [7- 3H] testosterone (Experiment 5) was chosen because aroma-
tization of androgens involves the removal of hydrogens at the lS and 2S 
positions (Kelly, 1974), and thus aromatization of [1,2,6,7- 3H] testos-
terone would result in a 50% reduction of the amount of estrogens 
detected, However, [7- 3H] testosterone has the disadvantage of only 
3 
having one-fourth the specific activity of [1,2,6,7- H] testosterone. 
The results of Experiments 4 and 5 will be discussed together, and 
the similarities and differences between using either isotopic form of 
testosterone noted. An obvious difference between Experiments 4 and 5 is 
the lower uptake of radioactivity after infusion of [7- 3H] testosterone. 
This can be explained by the much lower specific activity of this radio-
isotope of testosterone. 
The radioactivity present in organic extracts of blood plasma of all 
animals was primarily attributed to [3H] testosterone. The [3H] testos-
terone was slightly, but not significantly, increased in the testosterone 
treated animal. The increase in plasma [3H] testosterone coincided with 
a slight decrease in the RCR of rats receiving testosterone implants 
(Experiment 2). 3 The increase in plasma [ H] testosterone concentration 
and the decrease in RCR suggests that testosterone filled Silastic cap-
sules may increase the capacity of plasma proteins to bind testosterone. 
Small amounts of both 3a-androstanediol and SS-androstanediol were 
detected in the organic extracts of plasma from all animals. While the 
source of these steroids can be attributed to leakage or secretion by 
some tissue it is also possible that these steroids were derived from Sa-
and SS-reduction or 3a-hydroxysteroid dehydrogenation of testosterone by 
cellular elements in the blood. The latter possibility appears likely 
because of the presence in whole blood and erythrocyte suspensions of a 
9S 
17S-hydroxysteroid dehydrogenase (van der Molen and Groen, 1968), 
No other metabolite of testosterone isolated in the organic extracts 
of blood plasma was in high enough concentration to indicate that the 
[3H] testosterone was metabolized in blood and subsequently taken up by 
the tissues. 
The radioactive metabolites present in tissues after infusion of 
[3H] testosterone were probably not due to blood remaining in the tissues 
since each animal was perfused with saline to avoid such contamination, 
Any radiolabeled metabolite remaining in the circulation system after 
perfusion with saline was probably higher in the liver than in any other 
tissue because the extensive vascular sinuses in the liver. However, the 
concentration of [3H] testosterone isolated from liver was extremely low, 
and the majority of radioactivity present in the liver of all treatments 
was retained as testosterone metabolites. Castration increased the 
amount of radioactivity retained by hepatic tissue in the form of Sa-
androstane-3S, 17S-diol, Sa- and SS-androstane-3a, 17S-diol and 
androsterone, Thus castration caused a feminization of the liver by ap-
parently increasing the Sa-reductase (Shrieffers, 1967). In addition, 
the results of this investigation agree with others showing that the 
liver of castrated animals had a greatly increased 3S-hydroxysteroid de-
hydrogenase activity (Ota, ~~., 1972). The apparent increased activity 
of these two enzyme systems in response to castration shows the sensi-
tivity of hepatic tissue to decreased circulating testosterone levels. 
On the other hand, testosterone treatment did not affect the metabolism 
of testosterone when compared to the liver of normal animals. This em-
phasizes that plasma testosterone levels are normal in the testosterone 
treated animals, and a continuous release of testosterone from the 
96 
Silastic capsule does not influence the steroid metabolizing enzymes in 
the liver, However, the liver of testosterone treated animals could 
still be involved in homeostasis by an increased conjugation and elimina-
tion of testosterone, This possibility was not tested in the present 
investigation but appears to represent an important physiological mechan-
ism by which the body can keep the circulating titer of testosterone 
within a normal range, The finding that testosterone promotes an in-
crease in conjugation of testosterone to sulfate (Burnstein, 1968) sup-
ports this possiblity. 
The prostate also responds to castration by showing an increased up-
take of radioactivity. This retention was mainly in the form of DHT and 
androsterone~ demonstrating the presence of Sa-reductase. The data of 
both Experiments 4 and 5 revealed that the prostate metabolizes testos-
terone to DHT (Liao and Fang, 1969) and DHT may be necessary in the 
prostate for androgen activity (Massa and Martini, 1974), 
The metabolism of testosterort'e to DHT in the prostate of castrate 
animals also indicates that infusion is a reliable method for studying 
steroid metabolism because the results of the present study agree with 
the findings in vitro or following a single injection in vivo which 
demonstrated the potential necessity of metabolism to DHT (Gloyna and 
Wilson, 1969; Bruchovsky and Wilson, 1968), 
The prostate of castrate animals also metabolized part of the in-
fused testosterone to estradiol and estrone. A function for this aroma-
tization cannot be deduced from the present investigation, although the 
estrogens may function in the prostate as in the testis (deJong, ~ ~., 
1974) to regulate the metabolism of testosterone within the prostate. 
This could be expected since numerous steroids have been found to inhibit 
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Sa-reductase activity in the prostate (Massa and Martini, 1971), 
The radioactivity present in the testis after infusion of either 
3 3 [7- H] or [1,2,6,7- H] testosterone was relatively low and the testis 
from both normal and testosterone treated animals showed a tendency to 
retain radioactive testosterone in an unmetabolized form (60%). Testis 
of testosterone treated rats appeared to accumulate and retain more [3H] 
testosterone than those of normal rats, Differences in the amount of [3H] 
testosterone retained may be due in part to the loss of germ cells in the 
testis of testosterone treated animals or it may be a function of the 
constant exposure to testosterone experienced by animals receiving a 
testosterone-filled Silastic capsule, Testis from testosterone treated 
and normal animals contained small amounts of radiolabeled dihydrotestos-
terone, 3a-androstanediol and the two estrogens. The presence of these 
metabolites coincides with in vitro studied (Rivarola and Podesta, 1972; 
Sowell, et ~,, 1974; deJong, ~ al., 1974), The Sa-reduced metabolites 
may be acting in the testis to control spermatogenesis while the estro-
gens may function as regulators of intratesticular testosterone synthesis 
(deJong, ~ ~·, 1974), 
The majority (40-SO%) of the radioactivity in the cerebral cortex 
was retained as [3H] testosterone, but a small amount of [3H] dihydrotes-
tosterone and [3H] 3a-androstanediol was present, indicating the presence 
of Sa-reductase and 3a-hydroxysteroid dehydrogenase in cerebral cortex 
tissue (Rommerts and van der Molen, 1971). Castration increased the up-
take of almost all of the compounds isolated indicating that the cerebral 
cortex may be dependent upon androgens. Although the uptake of radio-
activity in the cerebral cortex was relatively low, the demonstration in 
the present study that the cortex was capable of uptake and a small 
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amount of metabolism of infused testosterone indicates that androgens may 
in fact be acting on the cerebral cortex to regulate behavior (Sar and 
Stumpf, 1973). Thus, the cortex should not be considered a control tis-
sue when investigating uptake and metabolism of testosterone in neural 
tissues because the above results indicate that further studies should be 
conducted on the cerebral cortex to determine the significance of the 
binding of radioactivity to macromolecules in this tissue (Noess and 
Attramadal, 1974), A better control may be muscular tissue such as the 
diaphragm (Sar and Stumpf, 1973). 
Although uptake of radioactivity in the hypothalamus was primarily 
in the form of testosterone (40-50%), hypothalamic tissue from all groups 
metabolized both [7- 3H] and [1,2,6,7- 3H] testosterone to [3H] dihydrotes-
3 tosterone and [ H] estradiol, The exact extent to which these metabolites 
regulate secretion of gonadotropins (Jaffe, 1969; Naftolin, et al,, 1972) 
cannot be determined from the present study. However, since castration 
did increase the formation of dihydrotestosterone but neither treatment 
affected estradiol formation, it seems possible that if testosterone does 
act on the hypothalamus to regulate gonadotropin secretion, it does so 
via dihydrotestosterone or in combination with testosterone (Jaffe, 1969), 
Although testosterone-filled Silastic capsules did not affect the amount 
of [3H] testosterone converted to estrogens, the role of estradiol and 
estrone in decreasing gonadotropin secretion cannot be ruled out since 
estradiol has been found to be 60 times more potent than testosterone in 
inhibiting gonadotropin secretion (Verjans, ~~., 1974), 
3 3 After the infusion of both [7- H] and [1,2,6,7- H] testosterone, a 
majority (40%) of the radioactivity found in the pituitary gland of the 
three groups investigated was [3H] testosterone, A small quantity of 
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radioactivity was retained as [ 3H] dihydrotestosterone, [3H] estrone and 
[3H] estradiol, indicating the presence of Sa-reductase and aromatizing 
enzymes, However, the Sa-reductase was not increased by castration since 
this treatment did not increase the radioactivity isolated as [ 3H] 
dihydrotestosterone. Thus, the failuTe to detect a castration response 
3 following infusion of [ H] testosterone was contrary to the in vitro 
findings (Massa, et al., 1972), The radioactivity isolated as estrone 
and estradiol in the pituitary gland was higher after infusion of 
3 3 '> [1,2,6,7- H] than after [7- I-if testosterone. This can be explained by 
3 the much higher specific activity of [1,2,6,7- H] testosterone even 
though the tritiated molecules at positions 1 and 2 are possibly lost 
during aromatization. 
Infusion of [3H] testosterone~did, however, demonstrate that the 
pituitary gland of testosterone treated animals retained almost twice the 
amount of radioactive testosterone (dpm/100 mg) as did the pituitary of 
normal animals. Since circulating LH levels are low in testosterone 
treated animals (Berndtson, et al., 1974), testosterone released from 
Silastic capsules most likely acts on the pituitary gland in the form of 
testosterone to inhibit gonadotropin secretion. Thus, the results of 
Experiments 4 and S point to a direct action of testosterone on the 
pituitary gland to regulate the secretion of g-onadotropins. 
This investigation has presented quantitative in vivo information to 
show that the pituitary gland from animals receiving testosterone-filled 
Silastic capsules is unique, Testosterone can enhance its own uptake in 
the pituitary gland. The continuous release of testosterone from 
Silastic capsules rather than a quick pulse after a single injection may 
induce an increase in a "receptor•• for testosterone in the pituitary 
100 
gland. This seems to be a very real possibility because a receptor 
protein for testosterone in the pituitary gland of rats has been demon-
strated (Jouan, ~ al., 1973). Thus, the capacity of pituitary tissue to 
bind testosterone to a receptor may be more important for regulation of 
gonadotropin secretion than circulating testosterone concentrations. 
CHAPTER VI 
SUMMARY AND CONCLUSIONS 
Numerous investigators, using different species, have shown sub-
dermal steroid filled Silastic capsules offer promise as potential male 
contraceptives (Berndt son, et ~·, 1974; Desjardins, ~ ~·, 1974; Frick, 
1973). Using capsules of appropriate sizes, these investigators have 
been able to maintain normal plasma testosterone levels and accessory sex 
gland weights, yet, significantly decrease plasma gonadotropin levels and 
testis weights. The present study .was designed, in part, to investigate 
two closely related hypotheses of how testosterone filled Silastic cap-
sules act to decrease the gonadotropin secretion without any apparent 
reduction in plasma testosterone levels. One hypothesis was that the 
additional testosterone released from Silastic capsules is metabolized to 
a different hormonal steroid which decreases gonadotropin secretion and 
the other hypothesis was that this extra testosterone increased the up-
take of one of the metabolites of testosterone in the brain or pituitary 
gland of the testosterone treated animal thereby decreasing gonadotropin 
secretion. To test these hypotheses, it was decided to localize testos-
terone and some of its possible tritiated metabolites in various tissues 
of normal, castrate and testosterone treated male rats following continu-
ous infusion of radiolabeled testosterone. 
The results of Experiment 1 show that testosterone treated animals 
have normal accessory sex gland weights but testicular atrophy caused by 
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a Silastic capsule that released 120 ~g testosterone per day, 
Experiments 2 and 3 validate the use of constant infusions to study 
the uptake and metabolism of radioactive testosterone. Experiment 2 
showed that radiolabe1ed testosterone was in a steady state after 3 hr 
infusion and Experiment 3 indicated that radiolabeled and endogenous 
testosterone were metabolized in a similar manner. 
Experiments 4 and 5 showed a two-fold increased in the uptake of 
radioactivity as [3H] testosterone in the pituitary of the testosterone 
treated animal. The results of Experiments 4 and 5 also demonstrated 
that the hypothalamus and cerebral cortex was capable of uptake and 
metabolism of [3H] testosterone. The data for the prostate, as expected, 
showed an increased uptake of radioactivity in the form of [3H] dihydro-
testosterone after castration and the testis demonstrated the capacity to 
retain a small amount of [3H] estradiol and [3H] 5a-androstane-3a, 17S-
diol. Testosterone was highly metabolized in the liver and castration 
caused an increase in the uptake of radioactivity by hepatic tissue. The 
radioactivity in blood plasma was primarily in the form of [3H] testos-
terone, The failure to demonstrate the presence of testosterone 
metabolites found in the various tissues were not due to contamination of 
plasma remaining in the tissues after cold saline perfusion, 
In conclusion, the present investigation has demonstrated the valid-
ity of using the more advantageous constant infusion technique to study 
testosterone metabolism. In addition, this investigation has shown that 
testosterone from Silastic capsules enhances the uptake of testosterone 
in the pituitary gland to cause a decrease in gonadotropin secretion, 
Whether this increased uptake is due to an implant-induced increase in a 
"receptor" for testosterone remains to be determined. 
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Trivial Names, Abbreviations and Systematic Names 
of Steroids and Steroid Derivatives 
Trivial Names (Abbreviation) 
3a-androstanediol (3a-diol) 
3S-androstanediol (3S-diol) 
SS-androstanediol (SS-diol) 
3a-androstanediol acetate 
(3a-diol-A) 
Sa-androstanedione (Sa-stane) 
SS-androstanedione (SS-stane) 
Androstenedione (~4 -stene) 
Androsterone (andro) 
Androsterone acetate (andro-A) 
Sa-dihydrotestosterone (Sa DHT) 
SS-dihydrotestosterone (SS DHT) 
Sa-Dihydrotestosterone acetate 
(DHT-A) 
Sa-epiandrosterone (Sa-epiandro) 
SS-epiandrosterone (SS-epiandro) 
Epitestosterone (epitesto) 
Estradiol (E2) 
Estradiol acetate (E2-A) 
Systematic Name 
5a-androstane-3a, 17S-diol 
5a-androstane-3S, 17S-diol 
5S-androstane-3a, 17S-diol 
5a-androstane-3a, 17S-diol 
diacetate 
Sa-androstane-3, 17-dione 
SS-androstane-3, 17-dione 
4-androstene-3, 17 dione 
3a-hydroxy-5a-androstan-17-one 
3a-hydroxy-5a-androstan-17-one 
acetate 
17S-hydroxy-5a-androstan-3-one 
17S-hydroxy-5S-androstan-3-one 
17S-hydroxy-5a-androstan-3-one 
acetate 
3S-hydroxy-5a-androstan-17-one 
3S-hydroxy-5S-androstan-17-one 
17a-hydroxyandrost-4-en-3-one 
1,3,5(10)-estratriene-3, 17S-diol 
1,3,5(10)-estratriene-3, 17S-diol 
acetate 
3-hydroxy-1,3,5(10)-estratrien-
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